Castle Brands (ROX) 10-Q 8 Nov 18 2019 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Sep. 30, 2018	Nov. 07, 2018
Document And Entity Information
Entity Registrant Name	Castle Brands Inc
Entity Central Index Key	1,311,538
Document Type	10-Q
Document Period End Date	Sep. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Filer Category	Accelerated Filer
Entity Small Business Flag	false
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		168,701,129
Trading Symbol	ROX
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,019

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2018	Mar. 31, 2018
Current Assets
Cash and cash equivalents	$ 368,863	$ 376,987
Accounts receivable - net of allowance for doubtful accounts of $422,808 and $390,939 at September 30 and March 31, 2018, respectively	12,702,096	13,083,487
Inventories - net of allowance for obsolete and slow-moving inventory of $410,268 and $346,344 at September 30 and March 31, 2018, respectively	40,604,712	34,555,553
Prepaid expenses and other current assets	3,371,257	3,724,759
Total Current Assets	57,046,928	51,740,786
Equipment - net	762,290	839,409
Intangible assets - net of accumulated amortization of $8,710,096 and $8,485,253 at September 30 and March 31, 2018, respectively	5,744,102	5,968,945
Goodwill	496,226	496,226
Investment in non-consolidated affiliate, at equity	903,067	813,926
Restricted cash	360,025	382,279
Other assets	93,587	91,789
Total Assets	65,406,225	60,333,360
Current Liabilities
Current maturities of notes payable	127,154	176,148
Accounts payable	8,765,538	7,674,858
Accrued expenses	2,755,372	2,497,001
Due to shareholders and affiliates	1,792,386	2,785,910
Total Current Liabilities	13,440,450	13,133,917
Long-Term Liabilities
Credit facility, net (including $761,600 and $576,546 of related-party participation at September 30 and March 31, 2018, respectively)	22,182,692	18,505,897
Note payable - 11% Subordinated note	20,000,000	20,000,000
Notes payable - GCP Note	216,869	211,580
Deferred tax liability	485,604	485,484
Other	6,778	6,778
Total Liabilities	56,332,393	52,343,656
Commitments and Contingencies (Note 11)
Equity
Preferred stock, $.01 par value, 25,000,000 shares authorized, no shares issued and outstanding at September 30 and March 31, 2018
Common stock, $.01 par value, 300,000,000 shares authorized at September 30 and March 31, 2018, 168,553,992 and 166,330,733 shares issued and outstanding at September 30 and March 31, 2018, respectively	1,685,540	1,663,307
Additional paid-in capital	156,186,890	154,731,044
Accumulated deficit	(150,798,115)	(149,891,272)
Accumulated other comprehensive loss	(2,167,272)	(2,082,011)
Total controlling shareholders' equity	4,907,043	4,421,068
Noncontrolling interests	4,166,789	3,568,636
Total Equity, including noncontrolling interests	9,073,832	7,989,704
Total Liabilities and Equity	$ 65,406,225	$ 60,333,360

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2018	Mar. 31, 2018
Statement of Financial Position [Abstract]
Allowance for doubtful accounts receivable	$ 422,808	$ 390,939
Allowance for obsolete and slow moving inventory	410,268	346,344
Accumulated amortization of intangible assets	8,710,096	8,485,253
Due to related-party participation	$ 761,600	$ 576,546
Subordinated note payable, percent	11.00%	11.00%
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	25,000,000	25,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	168,553,992	166,330,733
Common stock, shares outstanding	168,553,992	166,330,733

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended		6 Months Ended
		Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
Sales, net	[1]	$ 23,310,163	$ 20,894,150	$ 46,414,551	$ 41,746,437
Cost of sales	[1]	14,170,668	12,350,901	28,015,504	24,624,569
Gross profit		9,139,495	8,543,249	18,399,047	17,121,868
Selling expense		5,322,430	4,899,208	11,144,320	10,955,407
General and administrative expense		2,564,246	2,298,882	5,081,512	4,561,879
Depreciation and amortization		204,380	186,283	440,172	391,235
Income from operations		1,048,439	1,158,876	1,733,043	1,213,347
Other expense, net		(8,506)	(59)	(8,911)	(59)
Income from equity investment in non-consolidated affiliate		55,113	29,846	89,141	71,595
Foreign exchange gain (loss)		2,918	18,853	47,382	(32,308)
Interest expense, net		(1,099,505)	(901,559)	(2,151,447)	(1,793,423)
(Loss) income before provision for income taxes		(1,541)	305,957	(290,792)	(540,848)
Income tax benefit (expense), net		217	(25,335)	(17,898)	(43,748)
Net (loss) income		(1,324)	280,622	(308,690)	(584,596)
Net income attributable to noncontrolling interests		(214,812)	(282,303)	(598,153)	(363,482)
Net loss attributable to common shareholders		$ (216,136)	$ (1,681)	$ (906,843)	$ (948,078)
Net loss per common share, basic and diluted, attributable to common shareholders		$ 0	$ 0	$ (0.01)	$ (0.01)
Weighted average shares used in computation, basic and diluted, attributable to common shareholders		166,497,681	163,209,562	166,011,668	163,138,853
[1]	Sales, net and Cost of sales include excise taxes of $1,752,916 and $1,759,630 for the three months ended September 30, 2018 and 2017, respectively, and $3,587,170 and $3,399,385 for the six months ended September 30, 2018 and 2017, respectively

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
Excise taxes	$ 1,752,916	$ 1,759,630	$ 3,587,170	$ 3,399,385

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (1,324)	$ 280,622	$ (308,690)	$ (584,596)
Other comprehensive (loss) income:
Foreign currency translation adjustment	(8,932)	55,697	(85,261)	159,812
Total other comprehensive (loss) income:	(8,932)	55,697	(85,261)	159,812
Comprehensive (loss) income	$ (10,256)	$ 336,319	$ (393,951)	$ (424,784)

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Changes in Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Noncontrolling Interests [Member]	Total
Balance at Mar. 31, 2018	$ 1,663,307	$ 154,731,044	$ (149,891,272)	$ (2,082,011)	$ 3,568,636	$ 7,989,704
Balance, shares at Mar. 31, 2018	166,330,733
Net loss			(690,707)		383,341	(307,366)
Foreign currency translation adjustment				(76,329)		(76,329)
Exercise of common stock options	$ 5,032	210,984				216,016
Exercise of common stock options, shares	503,166
Restricted share grants	$ 11,000	(11,000)
Restricted share grants, shares	1,100,000
Common stock purchased under employee stock purchase plan	$ 419	40,540				40,959
Common stock purchased under employee stock purchase plan, shares	41,902
Stock-based compensation		490,485				490,485
Balance at Jun. 30, 2018	$ 1,679,758	155,462,053	(150,581,979)	(2,158,340)	3,951,977	8,353,469
Balance, shares at Jun. 30, 2018	167,975,801
Balance at Mar. 31, 2018	$ 1,663,307	154,731,044	(149,891,272)	(2,082,011)	3,568,636	7,989,704
Balance, shares at Mar. 31, 2018	166,330,733
Net loss						(308,690)
Foreign currency translation adjustment						$ (85,261)
Exercise of common stock options, shares						1,129,166
Balance at Sep. 30, 2018	$ 1,685,540	156,186,890	(150,798,115)	(2,167,272)	4,166,789	$ 9,073,832
Balance, shares at Sep. 30, 2018	168,553,992
Balance at Jun. 30, 2018	$ 1,679,758	155,462,053	(150,581,979)	(2,158,340)	3,951,977	8,353,469
Balance, shares at Jun. 30, 2018	167,975,801
Net loss			(216,136)		214,812	(1,324)
Foreign currency translation adjustment				(8,932)		(8,932)
Exercise of common stock options	$ 6,260	227,141				233,401
Exercise of common stock options, shares	626,000
Restricted shares forfeited	$ (478)	478
Restricted shares forfeited, shares	(47,809)
Stock-based compensation		497,219				497,219
Balance at Sep. 30, 2018	$ 1,685,540	$ 156,186,890	$ (150,798,115)	$ (2,167,272)	$ 4,166,789	$ 9,073,832
Balance, shares at Sep. 30, 2018	168,553,992

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (308,690)	$ (584,596)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	440,172	391,235
Provision for doubtful accounts	29,118	30,812
Amortization of deferred financing costs	48,280	38,960
Deferred income tax benefit, net	120	670
Net income from equity investment in non-consolidated affiliate	(89,141)	(71,595)
Effect of changes in foreign currency translation	(47,382)	32,308
Stock-based compensation expense	987,704	979,816
Addition to provision for obsolete inventories	160,000	50,000
Changes in operations, assets and liabilities:
Accounts receivable	342,426	712,811
Inventory	(6,251,694)	(4,363,236)
Prepaid expenses and supplies	349,956	(409,020)
Other assets	(23,382)	(32,401)
Accounts payable and accrued expenses	1,372,142	2,891,322
Accrued interest	5,289	5,289
Due to related parties	(993,524)	301,444
Total adjustments	(3,669,916)	558,415
NET CASH USED IN OPERATING ACTIVITIES	(3,978,606)	(26,181)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(112,644)	(84,251)
Acquisition of intangible assets		(22,265)
Investment in non-consolidated affiliate, at equity		(156,000)
NET CASH USED IN INVESTING ACTIVITIES	(112,644)	(262,516)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net borrowings on credit facility	3,650,100	(194,909)
Net payments on foreign revolving credit facility	(42,263)
Proceeds from issuance of common stock under employee stock purchase plan	40,959
Proceeds from exercise of common stock options	449,416	182,139
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	4,098,212	(12,770)
EFFECTS OF FOREIGN CURRENCY TRANSLATION	(37,340)	47,913
NET DECREASE IN CASH AND CASH EQUIVALENTS	(30,378)	(253,554)
CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH – BEGINNING	759,266	942,503
CASH AND CASH EQUIVALENTS	368,863	322,529
RESTRICTED CASH	360,025	366,420
CASH AND CASH EQUIVALENTS INCLUDING RESTRICTED CASH - ENDING	728,888	688,949
Schedule of non-cash financing activities
Conversion of 5% convertible note to common stock		25,000
Interest paid	2,062,386	1,685,662
Income taxes paid	$ 104,975	$ 669,500

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Cash Flows (Parenthetical)	3 Months Ended		6 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2017
Statement of Cash Flows [Abstract]
Conversion of convertible notes, percent	5.00%	5.00%	5.00%

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	6 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Organization and Summary of Significant Accounting Policies	NOTE 1 - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed consolidated financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and U.S. generally accepted accounting principles (“GAAP”) and, in the opinion of management, contain all adjustments (which consist of only normal recurring adjustments) necessary for a fair presentation of such financial information. Results of operations for interim periods are not necessarily indicative of those to be achieved for full fiscal years. The condensed consolidated balance sheet as of March 31, 2018 is derived from the March 31, 2018 audited financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with Castle Brands Inc.’s (the “Company”) audited consolidated financial statements for the fiscal year ended March 31, 2018 included in the Company’s annual report on Form 10-K for the year ended March 31, 2018, as amended (“2018 Form 10-K”). Please refer to the notes to the audited consolidated financial statements included in the 2018 Form 10-K for additional disclosures and a description of accounting policies. A. Description of business B. Liquidity C. Organization and operations D. Revenue The Company does not ship product unless it has received an order or other documentation authorizing delivery to its customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The Company generally does not provide post-delivery services and does not offer a right-of-return except in the case of an error. Uncollectable accounts receivable are estimated by using a combination of historical customer experience and a customer-by-customer analysis. The Company’s payment terms vary by customer and, in certain cases, the products offered. The term between invoicing and when payment is due is not significant. As permitted under U.S. GAAP, the Company has elected not to assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised goods to the customer will be one year or less. As permitted under U.S. GAAP, the Company has elected to recognize the incremental costs of obtaining a contract as an expense when incurred as the amortization period of the asset that the Company otherwise would have recognized will be one year or less. As permitted under U.S. GAAP, the Company has elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer, i.e excise taxes (see note 1H). As permitted under U.S. GAAP, the Company has elected to account for any shipping and handling activities that occur after a customer obtains control of any goods as activities to fulfill the promise to transfer the goods, and the Company is not required to evaluate whether such shipping and handling activities are promised services to its customers. See Note 13 for disaggregation of revenue by segment and product as the Company believes this best depicts how the nature, amount, timing and uncertainty of its revenues and cash flows are affected by economic factors. The Company does not have any customer contracts that meet the definition of unsatisfied performance obligations in accordance with U.S. GAAP. E. Equity investments F. Goodwill and other intangible assets G. Impairment of long-lived assets H. Excise taxes and duty I. Foreign currency J. Fair value of financial instruments The Company’s investments are reported at fair value in accordance with authoritative guidance, which accomplishes the following key objectives: - Defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; - Establishes a three-level hierarchy (“valuation hierarchy”) for fair value measurements; - Requires consideration of the Company’s creditworthiness when valuing liabilities; and - Expands disclosures about instruments measured at fair value. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of the valuation hierarchy are as follows: - Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. - Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are directly or indirectly observable for the asset or liability for substantially the full term of the financial instrument. - Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value measurement. K. Income taxes The 2017 Tax Act reduced the U.S. federal corporate tax rate from 35.0% to 21.0% for all corporations effective January 1, 2018. For fiscal year companies, the change in law requires the application of a blended rate for each quarter of the fiscal year, which in the Company’s case is 30.79% for the fiscal year ended March 31, 2018. Thereafter, the applicable statutory rate is 21.0%. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided to the extent a deferred tax asset is not considered recoverable. The Company has adopted the provisions of ASC 740 and at each of September 30 and March 31, 2018, the Company had reserves for uncertain tax positions (including related interest and penalties) for various state and local taxes of $6,778. The Company recognizes interest and penalties related to uncertain tax positions in general and administrative expense. L. Recent accounting pronouncements In July 2018, the FASB issued ASU 2018-09, “Codification Improvements.” This ASU makes amendments to multiple codification Topics. The transition and effective date guidance is based on the facts and circumstances of each amendment. Some of the amendments in this ASU do not require transition guidance and will be effective upon issuance of this ASU. However, many of the amendments in this ASU do have transition guidance with effective dates for annual periods beginning after December 15, 2018. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition. In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.” This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. This ASU also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). This guidance is effective for the Company as of April 1, 2019, with early adoption permitted. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition. In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”), which provides guidance for accounting for leases. ASU 2016-02 requires lessees to classify leases as either finance or operating leases and to record a right-of-use asset and a lease liability for all leases with a term greater than 12 months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized based on an effective interest rate method or on a straight line basis over the term of the lease. For leases with a term of 12 months or less for which there is not an option to purchase the underlying asset that the lessee is reasonably certain to exercise, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities and should recognize lease expense for such leases generally on a straight-line basis over the lease term. Certain qualitative disclosures along with specific quantitative disclosures will be required so that users are able to understand more about the nature of an entity’s leasing activities. Accounting for lessors remains largely unchanged from current U.S. GAAP. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases and ASU 2018-11 “Leases (Topic 842): Targeted Improvements” (ASU 2018-11). ASU 2018-10 clarifies certain areas within ASU 2016-02. Prior to ASU 2018-11, a modified retrospective transition was required for financing or operating leases existing at or entered into after the beginning of the earliest comparative period presented in the financial statements. ASU 2018-11 allows entities an additional transition method to the existing requirements whereby an entity could adopt the provisions of ASU 2016-02 by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption without adjustment to the financial statements for periods prior to adoption. ASU 2018-11 also allows a practical expedient that permits lessors to not separate non-lease components from the associated lease component if certain conditions are present. An entity that elects to use the practical expedients will, in effect, continue to account for leases that commenced before the effective date in accordance with previous GAAP unless the lease is modified, except that lessees are required to recognize a right-of-use asset and a lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental payments that were tracked and disclosed under previous GAAP. ASU 2016-02, ASU 2018-10 and ASU 2018-11 will be effective for the Company’s fiscal year beginning April 1, 2019 and subsequent interim periods. The Company’s current lease arrangements expire through 2021 and the Company is currently evaluating the impact the adoption of these ASUs will have on the Company’s condensed consolidated financial statements. The Company does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed consolidated financial statements. M. Accounting standards adopted In May 2017, the FASB issued ASU 2017-09, “Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting.” ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. This guidance became effective for the Company as of April 1, 2018. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In February 2017, the FASB issued ASU 2017-05, “Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20): Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets.” ASU 2017-05 clarifies the scope and accounting of a financial asset that meets the definition of an “in-substance nonfinancial asset” and defines the term “in-substance nonfinancial asset.” ASU 2017-05 also adds guidance for partial sales of nonfinancial assets. This guidance became effective for the Company as of April 1, 2018. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business.” This ASU, which must be applied prospectively, provides a narrower framework to be used to determine if a set of assets and activities constitutes a business than under current guidance and is generally expected to result in greater consistency in the application of ASC Topic 805, Business Combinations. This guidance became effective for the Company as of April 1, 2018. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In November 2016, the FASB issued ASU No. 2016-18, “Statement of Cash Flows (Topic 230): Restricted Cash, a consensus of the FASB’s Emerging Issues Task Force (the “Task Force”).” The new standard requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Entities will also be required to reconcile such total to amounts on the balance sheet and disclose the nature of the restrictions. The Company adopted the new standard on April 1, 2018 using a retrospective adoption method, which resulted in an adjustment to “Cash and cash equivalents including restricted cash” on the accompanying condensed consolidated statement of cashflows. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In October 2016, the FASB issued ASU 2016-16, “Income Taxes: Intra-Entity Transfers of Assets Other than Inventory.” This ASU removes the prohibition against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. This guidance became effective for the Company as of April 1, 2018. Entities must apply a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments”, which provides guidance on eight cash flow classification issues with the objective of reducing differences in practice. The new standard became effective for the Company as of April 1, 2018. Adoption is required to be on a retrospective basis, unless impracticable for any of the amendments, in which case a prospective application is permitted. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2016-08”). ASU 2016-08 does not change the core principle of the guidance stated in ASU 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASU 2014-9”), instead, the amendments in this ASU are intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations and whether an entity reports revenue on a gross or net basis. ASU 2016-08 will have the same effective date and transition requirements as the new standard issued in ASU 2014-09. In May 2014, the FASB issued ASU 2014-09. The new standard outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The new standard contains principles to determine the measurement of revenue and timing of when it is recognized. The guidance provides a five-step analysis of transactions to determine when and how revenue is recognized. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted the new standard on April 1, 2018 by applying the modified retrospective method, which did not result in a transition adjustment nor an adjustment to opening retained earnings. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In January 2016, the FASB issued ASU 2016-01, “Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities”, which amends the guidance in U.S. GAAP on the classification and measurement of financial instruments. Changes to the current guidance primarily affect the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. Also, the ASU clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The Company adopted the new standard on April 1, 2018, which did not result in a cumulative-effect adjustment to the balance sheet. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition.

Basic and Diluted Net Loss Per

Basic and Diluted Net Loss Per Common Share	6 Months Ended
	Sep. 30, 2018
Earnings Per Share [Abstract]
Basic and Diluted Net Loss Per Common Share	NOTE 2 - BASIC AND DILUTED NET LOSS PER COMMON SHARE Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed giving effect to all potentially dilutive common shares that were outstanding during the period that are not anti-dilutive. Potentially dilutive common shares consist of incremental shares issuable upon exercise of stock options, vesting of restricted shares or conversion of convertible notes outstanding. In computing diluted net income per share for the three months ended September 30, 2018 and 2017, no adjustment has been made to the weighted average outstanding common shares for the assumed exercise of stock options, vesting of restricted shares or conversion of convertible notes as the assumed exercise, vesting or conversion of these securities is anti-dilutive. Potential common shares not included in calculating diluted net loss per share are as follows: Three months ended September 30, 2018 2017 Stock options 14,171,442 15,523,008 Unvested restricted stock 1,997,750 1,092,000 5% Convertible notes 55,556 1,833,333 Total 16,224,748 18,448,341

Inventories

Inventories	6 Months Ended
	Sep. 30, 2018
Inventory Disclosure [Abstract]
Inventories	NOTE 3 - INVENTORIES September 30, 2018 March 31, 2018 Raw materials $ 25,080,981 $ 21,015,172 Finished goods - net 15,523,731 13,540,381 Total $ 40,604,712 $ 34,555,553 As of September 30 and March 31, 2018, 6% and 9%, respectively, of raw materials and 6% and 3%, respectively, of finished goods were located outside of the United States. In the six months ended September 30, 2018, the Company acquired $7,490,366 of bulk bourbon whiskey in support of its anticipated near and mid-term needs. The Company estimates the allowance for obsolete and slow-moving inventory based on analyses and assumptions including, but not limited to, historical usage, expected future demand and market requirements. Inventories are stated at the lower of weighted average cost or net realizable value.

Equity Investment

Equity Investment	6 Months Ended
	Sep. 30, 2018
Investments, Debt and Equity Securities [Abstract]
Equity Investment	NOTE 4 - EQUITY INVESTMENT Investment in Gosling-Castle Partners Inc., consolidated In March 2017, the Company acquired an additional 201,000 shares (the “GCP Share Acquisition”) of the common stock of GCP, representing a 20.1% equity interest in GCP. GCP is a strategic global export venture between the Company and the Gosling family. As a result of the completion of the GCP Share Acquisition, the Company’s total equity interest in GCP increased to 80.1%. The consideration for the GCP Share Acquisition was (i) $20,000,000 in cash and (ii) 1,800,000 shares of common stock of the Company. The Company accounted for this transaction in accordance with ASC 810 “Consolidation,” and in particular section 810-10-45. For the three months ended September 30, 2018 and 2017, GCP had pretax net income on a stand-alone basis of $1,415,600 and $1,425,534, respectively. The Company allocated a portion of this net income, or $281,704 and $283,681, to non-controlling interest for the three months ended September 30, 2018 and 2017, respectively. For the six months ended September 30, 2018 and 2017, GCP had pretax net income on a stand-alone basis of $3,341,936 and $1,851,541, respectively. The Company allocated a portion of this net income, or $665,045 and $368,457, to non-controlling interest for the three months ended September 30, 2018 and 2017, respectively. The cumulative balance allocated to noncontrolling interests in GCP was $4,166,789 and $3,568,636 at September 30 and March 31, 2018, respectively, as shown on the accompanying condensed consolidated balance sheets. Investment in Copperhead Distillery Company, equity method In June 2015, CB-USA purchased 20% of Copperhead Distillery Company (“Copperhead”) for $500,000. Copperhead owns and operates the Kentucky Artisan Distillery. The investment was part of an agreement to build a new warehouse in Crestwood, Kentucky to store Jefferson’s bourbons, provide distilling capabilities using special mash-bills made from locally grown grains and create a visitor center and store to enhance the consumer experience for the Jefferson’s brand. In September 2017, CB-USA purchased an additional 5% of Copperhead for $156,000 from an existing shareholder. The Company has accounted for this investment under the equity method of accounting. For the three months ended September 30, 2018 and 2017, the Company recognized $55,113 and $29,846 of income from this investment, respectively. For the six months ended September 30, 2018 and 2017, the Company recognized $89,141 and $71,595 of income from this investment, respectively. The investment balance was $903,067 and $813,926 at September 30 and March 31, 2018, respectively.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Sep. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	NOTE 5 - GOODWILL AND INTANGIBLE ASSETS The carrying amount of goodwill was $496,226 at each of September 30 and March 31, 2018. Intangible assets consist of the following: September 30, 2018 March 31, 2018 Definite life brands $ 170,000 $ 170,000 Trademarks 641,693 641,693 Rights 8,271,555 8,271,555 Product development 208,518 208,518 Patents 994,000 994,000 Other 55,460 55,460 10,341,226 10,341,226 Less: accumulated amortization 8,710,096 8,485,253 Net 1,631,130 1,855,973 Other identifiable intangible assets - indefinite lived* 4,112,972 4,112,972 $ 5,744,102 $ 5,968,945 * Other identifiable intangible assets - indefinite lived consists of product formulations and the Company’s relationships with its distillers. Accumulated amortization consists of the following: September 30, 2018 March 31, 2018 Definite life brands $ 170,000 $ 170,000 Trademarks 421,836 403,617 Rights 7,122,925 6,954,303 Product development 52,748 47,880 Patents 942,587 909,453 Accumulated amortization $ 8,710,096 $ 8,485,253

Restricted Cash

Restricted Cash	6 Months Ended
	Sep. 30, 2018
Restricted Cash
Restricted Cash	NOTE 6 - RESTRICTED CASH At September 30 and March 31, 2018, the Company had €310,334 or $360,025 (translated at the September 30, 2018 exchange rate) and €310,324 or $382,279 (translated at the March 31, 2018 exchange rate), respectively, of cash restricted from withdrawal and held by a bank in Ireland as collateral for overdraft coverage, creditors’ insurance, customs and excise guaranty and a revolving credit facility as described in Note 7A below.

Notes Payable

Notes Payable	6 Months Ended
	Sep. 30, 2018
Debt Disclosure [Abstract]
Notes Payable	NOTE 7 - NOTES PAYABLE September 30, 2018 March 31, 2018 Notes payable consist of the following: Foreign revolving credit facilities (A) $ 77,154 $ 126,148 Note payable - GCP note (B) 216,869 211,580 Credit facility (C) 22,182,692 18,505,897 5% Convertible notes (D) 50,000 50,000 11% Subordinated Note (E) 20,000,000 20,000,000 Total $ 42,599,085 $ 38,893,625 A. The Company has arranged various credit facilities aggregating €310,334 or $360,025 (translated at the September 30, 2018 exchange rate) and €310,324 or $382,279 (translated at the March 31, 2018 exchange rate) at September 30 and March 31, 2018, respectively, with an Irish bank, including overdraft coverage, creditors’ insurance, customs and excise guaranty, a revolving credit facility and Company credit cards. These credit facilities are payable on demand, continue until terminated by either party, are subject to annual review, and call for interest at the lender’s AA1 Rate minus 1.70%. At September 30 and March 31, 2018, there was €66,505 or $77,154 (translated at the September 30, 2018 exchange rate) and €102,404 or $126,148 (translated at the March 31, 2018 exchange rate) of principal due on the foreign revolving credit facilities included in current maturities of notes payable, respectively. B. In December 2009, GCP issued a promissory note (the “GCP Note”) in the aggregate principal amount of $211,580 to Gosling’s Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1, 2020, is payable at maturity, subject to certain acceleration events, and calls for annual interest of 5%, to be accrued and paid at maturity. At March 31, 2018, $10,579 of accrued interest was converted to amounts due to affiliates. At September 30, 2018, $216,869, consisting of $211,580 of principal and $5,289 of accrued interest, due on the GCP Note is included in long-term liabilities. At March 31, 2018, $211,580 of principal due on the GCP Note is included in long-term liabilities. C. In August 2011, the Company and CB-USA entered into a loan and security agreement (as amended and restated, and further amended, the “Amended Agreement”) with a third-party lender ACF FinCo I LP (“ACF,”) as successor in interest, which, as amended, provided for availability (subject to certain terms and conditions) of a facility of up to $21.0 million (the “Credit Facility”) for the purpose of providing the Company with working capital., including a sublimit in the maximum principal amount of $7,000,000 to permit the Company to acquire aged whiskey inventory (the “Purchased Inventory Sublimit”) subject to certain conditions set forth in the Amended Agreement. The Company and CB-USA are referred to individually and collectively as the Borrower. Pursuant to the Loan Agreement Amendment, the Company and CB-USA may borrow up to the lesser of (x) $21,000,000 and (y) the sum of the borrowing base calculated in accordance with the Amended Agreement and the Purchased Inventory Sublimit. In May 2018, the Company and CB-USA entered into a Fourth Amendment (the “Fourth Amendment”) to the Amended Agreement to amend certain terms of the Credit Facility. Among other changes, the Fourth Amendment increased the maximum amount of the Credit Facility from $21,000,000 to $23,000,000, and amended the definition of borrowing base to increase the amount of borrowing that can be collateralized by inventory. The Credit Facility interest rate is the rate that, when annualized, is the greatest of (a) the Prime Rate plus 3.00%, (b) the LIBOR Rate plus 5.50% and (c) 6.00%. As of September 30, 2018, the Credit Facility interest rate was 7.75%. The Purchased Inventory Sublimit interest rate is the rate that, when annualized, is the greatest of (a) the Prime Rate plus 4.25%, (b) the LIBOR Rate plus 6.75% and (c) 7.50%. As of September 30, 2018, the interest rate applicable to the Purchased Inventory Sublimit was 9.5%. The monthly facility fee is 0.75% per annum of the maximum Credit Facility. Also, the Company must pay a monthly facility fee of $2,000 with respect to the Purchased Inventory Sublimit until all obligations with respect thereof are fully paid and performed. The Amended Agreement contains EBITDA targets allowing for further interest rate reductions in the future. The Company and CB-USA are permitted to prepay the Credit Facility in whole or the Purchased Inventory Sublimit, in whole or in part, subject to certain prepayment penalties as set forth in the Loan Agreement Amendment. For the six months ended September 30, 2018, the Company paid interest at 7.31175% through April 30, 2018, then 7.35805% through May 31, 2018, then 7.30031% through June 30, 2018, then 7.5% through September 27, 2018, then 7.75% through September 30, 2018 on the Amended Agreement. For the six months ended September 30, 2017, the Company paid interest at 6.5% through June 14, 2017, then 6.75% through September 30, 2017 on the Amended Agreement. For the six months ended September 30, 2018, the Company paid interest at 9.06175% through April 30, 2018, then 9.10805% through May 31, 2018, then 9.05031% through June 30, 2018, then 9.25% through September 27, 2018, then 9.5% through September 30, 2018 on the Purchased Inventory Sublimit. For the six months ended September 30, 2017, the Company paid interest at 8.25% through June 14, 2017, and then at 8.5% through September 30, 2017 on the Purchased Inventory Sublimit. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Credit Facility. After the occurrence and during the continuance of any “Default” or “Event of Default” (as defined under the Amended Agreement), the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Credit Facility interest rate. There have been no Events of Default under the Credit Facility. ACF also receives a collateral management fee of $1,000 per month (increased to $2,000 after the occurrence of and during the continuance of an Event of Default) in addition to the facility fee with respect to the Purchased Inventory Sublimit. The Amended Agreement contains standard borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The Amended Agreement includes negative covenants that, among other things, restrict the Borrower’s ability to create additional indebtedness, dispose of properties, incur liens and make distributions or cash dividends. The obligations of the Borrower under the Amended Amendment are secured by the grant of a pledge and security interest in all of the assets of the Borrower. At September 30, 2018, the Company was in compliance, in all respects, with the covenants under the Amended Agreement. The Credit Facility matures on July 31, 2020. ACF required as a condition to entering into an amendment to the Amended Agreement in August 2015 that ACF enter into a participation agreement with certain related parties of the Company, including Frost Gamma Investments Trust, an entity affiliated with Phillip Frost, M.D., a director and principal shareholder of the Company, Mark E. Andrews, III, a director of the Company and the Company’s Chairman, Richard J. Lampen, a director of the Company and the Company’s President and Chief Executive Officer, Brian L. Heller, the Company’s General Counsel and Assistant Secretary, and Alfred J. Small, the Company’s Senior Vice President, Chief Financial Officer, Treasurer and Secretary, to allow for the sale of participation interests in the Purchased Inventory Sublimit and the inventory purchased with the proceeds thereof. The participation agreement provides that ACF’s commitment to fund each advance of the Purchased Inventory Sublimit shall be limited to seventy percent (70%), up to an aggregate maximum principal amount for all advances equal to $4,900,000. Neither the Company nor CB-USA is a party to the participation agreement. However, the Company and CB-USA are party to a fee letter with the junior participants (including the related party junior participants) pursuant to which the Company and CB-USA were obligated to pay the junior participants a closing fee of $18,000 on the effective date of the Loan Agreement Amendment and are obligated to pay a commitment fee of $18,000 on each anniversary of the effective date until the junior participants’ obligations are terminated pursuant to the participation agreement. In August 2015, the Company used $3,000,000 of the Purchased Inventory Sublimit to acquire aged bourbon inventory. Frost Gamma Investments Trust ($150,000), Mark E. Andrews, III ($50,000), Richard J. Lampen ($100,000), Brian L. Heller ($42,500) and Alfred J. Small ($15,000) each acquired participation interests in the Purchased Inventory Sublimit and the inventory purchased with the proceeds thereof. In January 2017, the Company acquired $1,030,000 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($51,500), Richard J. Lampen ($34,333), Mark E. Andrews, III ($17,167), Brian L. Heller ($14,592), and Alfred J. Small ($5,150), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In October 2017, the Company acquired $1,308,125 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($65,406), Richard J. Lampen ($43,604), Mark E. Andrews, III ($21,802), Brian L. Heller ($18,532), and Alfred J. Small ($6,541), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In December 2017, the Company acquired $900,425 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($45,021), Richard J. Lampen ($30,014), Mark E. Andrews, III ($15,007), Brian L. Heller ($12,756), and Alfred J. Small ($4,502), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In April 2018, the Company acquired $2,001,000 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($100,050), Richard J. Lampen ($66,700), Mark E. Andrews, III ($33,350), Brian L. Heller ($28,348), and Alfred J. Small ($10,005), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In June 2018, the Company acquired $1,035,000 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($51,750), Richard J. Lampen ($34,500), Mark E. Andrews, III ($17,250), Brian L. Heller ($14,663), and Alfred J. Small ($5,175), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. Under the terms of the participation agreement, the participants receive interest at the rate of 11% per annum. At September 30 and March 31, 2018, $22,255,062 and $18,604,962, respectively, due on the Credit Facility was included in long-term liabilities. At September 30 and March 31, 2018, there was $744,938 and $2,395,038, respectively, in potential availability under the Credit Facility. In connection with the adoption of ASU 2015-03, the Company included $72,370 and $99,065 of debt issuance costs at September 30 and March 31, 2018, respectively, as direct deductions from the carrying amount of the related debt liability. In October 2018, the Company and CB-USA entered into a Fifth Amendment (the “Fifth Amendment”) to the Amended Agreement to amend certain terms of the Company’s existing Credit Facility with ACF. Among other changes, the Fifth Amendment increased the maximum amount of the Credit Facility from $23,000,000 to $25,000,000, and amended the definition of borrowing base to increase the amount of borrowing that can be collateralized by inventory. The Company and CB-USA paid ACF an aggregate $50,000 commitment fee in connection with the Amendment. In connection with the Amendment, the Company and CB-USA also entered into an Amended and Restated Revolving Credit Note. In November 2018, the Company and CB-USA entered into a Sixth Amendment (the “Sixth Amendment”) to the Amended Agreement to amend certain terms of the Company’s existing Credit Facility with ACF. Among other changes, the Sixth Amendment extends the term of the Credit Facility to July 31, 2020 and amended the definition of borrowing base to increase the amount of borrowing that can be collateralized by inventory. The Company and CB-USA paid ACF an aggregate $57,500 commitment fee in connection with the Amendment. D. In October 2013, the Company entered into a 5% Convertible Subordinated Note Purchase Agreement (the “Note Purchase Agreement”) with the purchasers party thereto, under which the Company issued an aggregate initial principal amount of $2,125,000 of unsecured subordinated notes (the “Convertible Notes”). The Convertible Notes bear interest at a rate of 5% per annum, payable quarterly, until their maturity date of December 15, 2018. The Convertible Notes, and accrued but unpaid interest thereon, are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Company’s common stock at a conversion price of $0.90 per share (the “Conversion Price”). The Convertible Notes may be prepaid in whole or in part at any time without penalty or premium, but with payment of accrued interest to the date of prepayment. The Convertible Notes contain customary events of default, which, if uncured, entitle each note holder to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the Convertible Notes. The purchasers of the Convertible Notes included related parties of the Company, including an affiliate of Dr. Phillip Frost ($500,000), Mark E. Andrews, III ($50,000), an affiliate of Richard J. Lampen ($50,000), an affiliate of Glenn Halpryn ($200,000), Dennis Scholl ($100,000), and Vector Group Ltd., a more than 5% shareholder of ours, of which Richard Lampen is an executive officer, Henry Beinstein, a director of ours, is a director and Phillip Frost, M.D. is a principal shareholder ($200,000). The Company may forcibly convert all or any part of the Convertible Notes and all accrued but unpaid interest thereon if (i) the average daily volume of the Company’s common stock (as reported on the principal market or exchange on which the common stock is listed or quoted for trading) exceeds $50,000 per trading day and (ii) the volume weighted average price of the common stock for at least twenty (20) trading days during any thirty (30) consecutive trading day period exceeds 250% of the then-current Conversion Price. Any forced conversion will be applied ratably to the holders of all Convertible Notes issued pursuant to the Note Purchase Agreement based on each holder’s then-current note holdings. In connection with the Note Purchase Agreement, each purchaser of the Convertible Notes was required to execute a joinder to the subordination agreement, by and among ACF and certain other junior lenders to the Company; the Company is not a party to the subordination agreement. During the year ended March 31, 2018, certain holders of the Convertible Notes converted an aggregate $1,632,000 of the outstanding principal and interest balances of their Convertible Notes into 1,813,334 shares of the Company’s common stock, pursuant to the terms of the Convertible Notes. The converting holders included an affiliate of Dr. Phillip Frost, Mark E. Andrews, III an affiliate of Richard J. Lampen, and Vector Group Ltd. At each of September 30 and March 31, 2018, $50,000 of principal due on the Convertible Notes was included in current maturities of notes payable. E. In March 2017, the Company issued a promissory note to Frost Nevada Investments Trust (the “Holder”), an entity affiliated with Phillip Frost, M.D., in the aggregate principal amount of $20,000,000 (the “Subordinated Note”). The purpose of Company’s issuance of the Subordinated Note was to finance the GCP Share Acquisition. The Subordinated Note bears interest quarterly at the rate of 11% per annum. All claims of the Holder to principal, interest and any other amounts owed under the Subordinated Note are subordinated in right of payment to all indebtedness of the Company existing as of the date of the Subordinated Note. The Subordinated Note contains customary events of default and may be prepaid by the Company, in whole or in part, without penalty, at any time. In April 2018, the Company entered into a First Amendment to the Subordinated Note to extend the maturity date on the Subordinated Note from March 15, 2019 until September 15, 2020. No other provisions of the Subordinated Note were amended.

Equity

Equity	6 Months Ended
	Sep. 30, 2018
Equity [Abstract]
Equity	NOTE 8 - EQUITY Restricted Share Grants

Foreign Currency Forward Contra

Foreign Currency Forward Contracts	6 Months Ended
	Sep. 30, 2018
Foreign Currency [Abstract]
Foreign Currency Forward Contracts	NOTE 9 - FOREIGN CURRENCY FORWARD CONTRACTS The Company enters into forward contracts from time to time to reduce its exposure to foreign currency fluctuations. The Company recognizes in the balance sheet derivative contracts at fair value, and reflects any net gains and losses currently in earnings. At September 30 and March 31, 2018, the Company had no forward contracts outstanding.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation	NOTE 10 - STOCK-BASED COMPENSATION In April 2018, the Company granted to employees, directors and certain consultants an aggregate of 1,100,000 restricted shares of the Company’s common stock under the Company’s 2013 Incentive Compensation Plan. The restricted shares vest 25% on each of the first four anniversaries of the grant date, subject to earlier vesting in certain circumstances. The Company has valued the shares at $1,342,000. Stock-based compensation expense for the three months ended September 30, 2018 and 2017 amounted to $497,219 and $504,490, respectively. Stock-based compensation expense for the six months ended September 30, 2018 and 2017 amounted to $987,704 and $979,816, respectively. At September 30, 2018, total unrecognized compensation cost amounted to $3,645,961, representing 2,154,875 unvested options and 1,997,750 unvested shares of restricted stock. This cost is expected to be recognized over a weighted-average vesting period of 1.91 years. There were 1,129,166 options exercised during the six months ended September 30, 2018 and 240,300 options exercised during the six months ended September 30, 2017. The Company did not recognize any related tax benefit for the three months ended June 30, 2018 and 2017 from option exercises, as the effects were de minimis.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 11 - COMMITMENTS AND CONTINGENCIES A. The Company has entered into a supply agreement with an Irish distiller (“Irish Distillery”), which provides for the production of blended Irish whiskeys for the Company until the contract is terminated by either party in accordance with the terms of the agreement. The Irish Distillery may terminate the contract if it provides at least six years prior notice to the Company, except for breach. Under this agreement, the Company provides the Irish Distillery with a forecast of the estimated amount of liters of pure alcohol it requires for the next four fiscal contract years and agrees to purchase 90% of that amount, subject to certain annual adjustments. For the contract year ending June 30, 2019, the Company has contracted to purchase approximately €1,105,572 or $1,282,596 (translated at the September 30, 2018 exchange rate) in bulk Irish whiskey, of which €285,489, or $331,202 (translated at the September 30, 2018 exchange rate), has been purchased as of September 30, 2018. The Company is not obligated to pay the Irish Distillery for any product not yet received. During the term of this supply agreement, the Irish Distillery has the right to limit additional purchases above the commitment amount. B. The Company has also entered into a supply agreement with the Irish Distillery, which provides for the production of single malt Irish whiskeys for the Company until the contract is terminated by either party in accordance with the terms of the agreement. The Irish Distillery may terminate the contract if it provides at least thirteen years prior notice to the Company, except for breach. Under this agreement, the Company provides the Irish Distillery with a forecast of the estimated amount of liters of pure alcohol it requires for the next twelve fiscal contract years and agrees to purchase 80% of that amount, subject to certain annual adjustments. For the contract year ending June 30, 2019, the Company has contracted to purchase approximately €575,791 or $667,987 (translated at the September 30, 2018 exchange rate) in bulk Irish whiskey, of which €140,401, or $162,882 (translated at the September 30, 2018 exchange rate), has been purchased as of September 30, 2018. The Company is not obligated to pay the Irish Distillery for any product not yet received. During the term of this supply agreement, the Irish Distillery has the right to limit additional purchases above the commitment amount. C. The Company has entered into a supply agreement with a bourbon distiller, which provides for the production of newly-distilled bourbon whiskey. Under this agreement, the distiller will provide the Company with an agreed upon amount of original proof gallons of newly-distilled bourbon whiskey, subject to certain annual adjustments. For the contract year ending December 31, 2018, the Company has contracted to purchase approximately $3,900,000 in newly distilled bourbon, of which $1,682,200 has been purchased as of September 30, 2018. The Company is not obligated to pay the distiller for any product not yet received. D. The Company leases office space in New York, NY, Dublin, Ireland and Houston, TX. The New York, NY lease began on May 1, 2010 and expires on February 29, 2020 and provides for monthly payments of $26,255. The Dublin lease commenced on March 1, 2009 and extends through October 31, 2019 and provides for monthly payments of €1,500 or $1,740 (translated at the September 30, 2018 exchange rate). The Houston, TX lease commenced on April 27, 2015 and extends through June 26, 2021 and provides for monthly payments of $3,581. The Company has also entered into non-cancelable operating leases for certain office equipment. E. As described in Note 7C, in August 2011, the Company and CB-USA entered into the Credit Facility, as amended in July 2012, March 2013, August 2013, November 2013, August 2014, September 2014, August 2015, October 2017, May 2018 and October 2018. F. Except as set forth below, the Company believes that neither it, nor any of its subsidiaries, is currently subject to litigation which, in the opinion of management after consultation with counsel, is likely to have a material adverse effect on the Company. The Company may become involved in litigation from time to time relating to claims arising in the ordinary course of its business. These claims, even if not meritorious, could result in the expenditure of significant financial and managerial resources.

Concentrations

Concentrations	6 Months Ended
	Sep. 30, 2018
Risks and Uncertainties [Abstract]
Concentrations	NOTE 12 - CONCENTRATIONS A. Credit Risk B. Customers

Geographic Information

Geographic Information	6 Months Ended
	Sep. 30, 2018
Segment Reporting [Abstract]
Geographic Information	NOTE 13 - GEOGRAPHIC INFORMATION The Company operates in one reportable segment - the sale of premium beverage alcohol. The Company’s product categories are whiskeys, rum, liqueurs, vodka, tequila and ginger beer, a related non-alcoholic beverage product. The Company reports its operations in two geographic areas: International and United States. The consolidated financial statements include revenues and assets generated in or held in the U.S. and foreign countries. The following table sets forth the amounts and percentage of consolidated sales, net, consolidated income from operations, consolidated net loss attributable to common shareholders, consolidated income tax expense and consolidated assets from the U.S. and foreign countries and consolidated sales, net by category. Three months ended September 30, 2018 2017 Consolidated Sales, net: International $ 2,237,418 9.6 % $ 2,177,367 10.4 % U.S. - control states 4,519,667 21.4 % 4,365,492 23.3 % U.S. - open states 16,553,078 78.6 % 14,351,291 76.7 % United States 21,072,745 90.4 % 18,716,783 89.6 % Total Consolidated Sales, net $ 23,310,163 100.0 % $ 20,894,150 100.0 % Consolidated Income from Operations: International $ 24,211 2.3 % $ 15,737 1.4 % United States 1,024,228 97.7 % 1,143,139 98.6 % Total Consolidated Income from Operations $ 1,048,439 100.0 % $ 1,158,876 100.0 % Consolidated Net Income (Loss) Attributable to Common Shareholders: International $ 48,135 22.3 % $ 47,470 2,822.9 % United States (264,271 ) (122.3 )% (49,151 ) (2,922.9 )% Total Consolidated Net Loss Attributable to Common Shareholders $ (216,136 ) 100.0 % $ (1,681 ) 100.0 % Income tax expense, net: United States $ 217 100.0 % $ 25,335 100.0 % Consolidated Sales, net by category: Whiskey $ 9,000,528 38.6 % $ 7,335,290 35.2 % Rum 4,176,749 17.9 % $ 4,168,262 19.9 % Liqueurs 2,536,745 10.9 % 2,579,437 12.3 % Vodka 336,166 1.4 % 353,792 1.7 % Tequila 26,479 0.1 % 84,560 0.4 % Ginger beer 7,235,923 31.0 % 6,372,809 30.5 % Total Consolidated Sales, net $ 23,310,163 100.0 % $ 20,894,150 100.0 % Six months ended September 30, 2018 2017 Consolidated Sales, net: International $ 4,544,236 9.8 % $ 4,442,146 10.6 % U.S. - control states 9,831,306 23.5 % 8,644,802 23.2 % U.S. - open states 32,039,009 76.5 % 28,659,489 76.8 % United States 41,870,315 91.2 % 37,304,291 89.4 % Total Consolidated Sales, net $ 46,414,551 100.0 % $ 41,746,437 100.0 % Consolidated (Loss) Income from Operations: International $ (53,695 ) (3.1 )% $ (13,261 ) (1.1 )% United States 1,786,738 103.1 % 1,226,608 101.1 % Total Consolidated Income from Operations $ 1,733,043 100.0 % $ 1,213,347 100.0 % Consolidated Net (Loss) Income Attributable to Common Shareholders: International $ (867 ) 0.1 % $ 42,262 4.5 % United States (905,976 ) 99.9 % (990,340 ) (104.5 )% Total Consolidated Net Loss Attributable to Common Shareholders $ (906,843 ) 100.0 % $ (948,078 ) 100.0 % Income tax expense, net: United States $ (17,898 ) 100.0 % $ (43,748 ) 100.0 % Consolidated Sales, net by category: Whiskey $ 19,141,660 39.8 % $ 14,505,777 34.8 % Rum 8,733,772 18.8 % $ 8,621,765 20.7 % Liqueurs 4,523,841 9.7 % 4,638,346 11.1 % Vodka 656,744 1.4 % 643,255 1.5 % Tequila 85,162 0.2 % 129,736 0.3 % Ginger beer 13,932,543 30.0 % 13,207,558 31.6 % Total Consolidated Sales, net $ 46,414,551 100.0 % $ 41,746,437 100.0 % As of September 30, 2018 As of March 31, 2018 Consolidated Assets: International $ 2,501,001 3.8 % $ 2,886,735 4.8 % United States 62,905,365 96.2 % 57,446,625 95.2 % Total Consolidated Assets $ 65,406,366 100.0 % $ 60,333,360 100.0 %

Organization and Summary of S_2

Organization and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Description of Business	A. Description of business
Liquidity	B. Liquidity
Organization and Operations	C. Organization and operations
Revenues	D. Revenue The Company does not ship product unless it has received an order or other documentation authorizing delivery to its customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. The Company generally does not provide post-delivery services and does not offer a right-of-return except in the case of an error. Uncollectable accounts receivable are estimated by using a combination of historical customer experience and a customer-by-customer analysis. The Company’s payment terms vary by customer and, in certain cases, the products offered. The term between invoicing and when payment is due is not significant. As permitted under U.S. GAAP, the Company has elected not to assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised goods to the customer will be one year or less. As permitted under U.S. GAAP, the Company has elected to recognize the incremental costs of obtaining a contract as an expense when incurred as the amortization period of the asset that the Company otherwise would have recognized will be one year or less. As permitted under U.S. GAAP, the Company has elected to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from a customer, i.e excise taxes (see note 1H). As permitted under U.S. GAAP, the Company has elected to account for any shipping and handling activities that occur after a customer obtains control of any goods as activities to fulfill the promise to transfer the goods, and the Company is not required to evaluate whether such shipping and handling activities are promised services to its customers. See Note 13 for disaggregation of revenue by segment and product as the Company believes this best depicts how the nature, amount, timing and uncertainty of its revenues and cash flows are affected by economic factors. The Company does not have any customer contracts that meet the definition of unsatisfied performance obligations in accordance with U.S. GAAP.
Equity Investments	E. Equity investments
Goodwill and Other Intangible Assets	F. Goodwill and other intangible assets
Impairment of Long-lived Assets	G. Impairment of long-lived assets
Excise Taxes and Duty	H. Excise taxes and duty
Foreign Currency	I. Foreign currency
Fair Value of Financial Instruments	J. Fair value of financial instruments The Company’s investments are reported at fair value in accordance with authoritative guidance, which accomplishes the following key objectives: - Defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; - Establishes a three-level hierarchy (“valuation hierarchy”) for fair value measurements; - Requires consideration of the Company’s creditworthiness when valuing liabilities; and - Expands disclosures about instruments measured at fair value. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of the valuation hierarchy are as follows: - Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. - Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are directly or indirectly observable for the asset or liability for substantially the full term of the financial instrument. - Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value measurement.
Income Taxes	K. Income taxes The 2017 Tax Act reduced the U.S. federal corporate tax rate from 35.0% to 21.0% for all corporations effective January 1, 2018. For fiscal year companies, the change in law requires the application of a blended rate for each quarter of the fiscal year, which in the Company’s case is 30.79% for the fiscal year ended March 31, 2018. Thereafter, the applicable statutory rate is 21.0%. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided to the extent a deferred tax asset is not considered recoverable. The Company has adopted the provisions of ASC 740 and at each of September 30 and March 31, 2018, the Company had reserves for uncertain tax positions (including related interest and penalties) for various state and local taxes of $6,778. The Company recognizes interest and penalties related to uncertain tax positions in general and administrative expense.
Recent Accounting Pronouncements	L. Recent accounting pronouncements In July 2018, the FASB issued ASU 2018-09, “Codification Improvements.” This ASU makes amendments to multiple codification Topics. The transition and effective date guidance is based on the facts and circumstances of each amendment. Some of the amendments in this ASU do not require transition guidance and will be effective upon issuance of this ASU. However, many of the amendments in this ASU do have transition guidance with effective dates for annual periods beginning after December 15, 2018. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition. In June 2018, the FASB issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.” This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. This ASU also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). This guidance is effective for the Company as of April 1, 2019, with early adoption permitted. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition. In February 2016, the FASB issued ASU 2016-02, Leases (“ASU 2016-02”), which provides guidance for accounting for leases. ASU 2016-02 requires lessees to classify leases as either finance or operating leases and to record a right-of-use asset and a lease liability for all leases with a term greater than 12 months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized based on an effective interest rate method or on a straight line basis over the term of the lease. For leases with a term of 12 months or less for which there is not an option to purchase the underlying asset that the lessee is reasonably certain to exercise, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities and should recognize lease expense for such leases generally on a straight-line basis over the lease term. Certain qualitative disclosures along with specific quantitative disclosures will be required so that users are able to understand more about the nature of an entity’s leasing activities. Accounting for lessors remains largely unchanged from current U.S. GAAP. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases and ASU 2018-11 “Leases (Topic 842): Targeted Improvements” (ASU 2018-11). ASU 2018-10 clarifies certain areas within ASU 2016-02. Prior to ASU 2018-11, a modified retrospective transition was required for financing or operating leases existing at or entered into after the beginning of the earliest comparative period presented in the financial statements. ASU 2018-11 allows entities an additional transition method to the existing requirements whereby an entity could adopt the provisions of ASU 2016-02 by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption without adjustment to the financial statements for periods prior to adoption. ASU 2018-11 also allows a practical expedient that permits lessors to not separate non-lease components from the associated lease component if certain conditions are present. An entity that elects to use the practical expedients will, in effect, continue to account for leases that commenced before the effective date in accordance with previous GAAP unless the lease is modified, except that lessees are required to recognize a right-of-use asset and a lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental payments that were tracked and disclosed under previous GAAP. ASU 2016-02, ASU 2018-10 and ASU 2018-11 will be effective for the Company’s fiscal year beginning April 1, 2019 and subsequent interim periods. The Company’s current lease arrangements expire through 2021 and the Company is currently evaluating the impact the adoption of these ASUs will have on the Company’s condensed consolidated financial statements. The Company does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed consolidated financial statements.
Accounting Standards Adopted	M. Accounting standards adopted In May 2017, the FASB issued ASU 2017-09, “Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting.” ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. This guidance became effective for the Company as of April 1, 2018. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In February 2017, the FASB issued ASU 2017-05, “Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20): Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets.” ASU 2017-05 clarifies the scope and accounting of a financial asset that meets the definition of an “in-substance nonfinancial asset” and defines the term “in-substance nonfinancial asset.” ASU 2017-05 also adds guidance for partial sales of nonfinancial assets. This guidance became effective for the Company as of April 1, 2018. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business.” This ASU, which must be applied prospectively, provides a narrower framework to be used to determine if a set of assets and activities constitutes a business than under current guidance and is generally expected to result in greater consistency in the application of ASC Topic 805, Business Combinations. This guidance became effective for the Company as of April 1, 2018. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In November 2016, the FASB issued ASU No. 2016-18, “Statement of Cash Flows (Topic 230): Restricted Cash, a consensus of the FASB’s Emerging Issues Task Force (the “Task Force”).” The new standard requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Entities will also be required to reconcile such total to amounts on the balance sheet and disclose the nature of the restrictions. The Company adopted the new standard on April 1, 2018 using a retrospective adoption method, which resulted in an adjustment to “Cash and cash equivalents including restricted cash” on the accompanying condensed consolidated statement of cashflows. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In October 2016, the FASB issued ASU 2016-16, “Income Taxes: Intra-Entity Transfers of Assets Other than Inventory.” This ASU removes the prohibition against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. This guidance became effective for the Company as of April 1, 2018. Entities must apply a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments”, which provides guidance on eight cash flow classification issues with the objective of reducing differences in practice. The new standard became effective for the Company as of April 1, 2018. Adoption is required to be on a retrospective basis, unless impracticable for any of the amendments, in which case a prospective application is permitted. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2016-08”). ASU 2016-08 does not change the core principle of the guidance stated in ASU 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASU 2014-9”), instead, the amendments in this ASU are intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations and whether an entity reports revenue on a gross or net basis. ASU 2016-08 will have the same effective date and transition requirements as the new standard issued in ASU 2014-09. In May 2014, the FASB issued ASU 2014-09. The new standard outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The new standard contains principles to determine the measurement of revenue and timing of when it is recognized. The guidance provides a five-step analysis of transactions to determine when and how revenue is recognized. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted the new standard on April 1, 2018 by applying the modified retrospective method, which did not result in a transition adjustment nor an adjustment to opening retained earnings. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition. In January 2016, the FASB issued ASU 2016-01, “Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities”, which amends the guidance in U.S. GAAP on the classification and measurement of financial instruments. Changes to the current guidance primarily affect the accounting for equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. Also, the ASU clarifies guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on available-for-sale debt securities. The Company adopted the new standard on April 1, 2018, which did not result in a cumulative-effect adjustment to the balance sheet. The Company determined that the adoption of this guidance did not have a material effect on the Company’s results of operations, cash flows and financial condition.

Basic and Diluted Net Loss Pe_2

Basic and Diluted Net Loss Per Common Share (Tables)	6 Months Ended
	Sep. 30, 2018
Earnings Per Share [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Potential common shares not included in calculating diluted net loss per share are as follows: Three months ended September 30, 2018 2017 Stock options 14,171,442 15,523,008 Unvested restricted stock 1,997,750 1,092,000 5% Convertible notes 55,556 1,833,333 Total 16,224,748 18,448,341

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Sep. 30, 2018
Inventory Disclosure [Abstract]
Schedule of Inventory	September 30, 2018 March 31, 2018 Raw materials $ 25,080,981 $ 21,015,172 Finished goods - net 15,523,731 13,540,381 Total $ 40,604,712 $ 34,555,553

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Sep. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Intangible assets consist of the following: September 30, 2018 March 31, 2018 Definite life brands $ 170,000 $ 170,000 Trademarks 641,693 641,693 Rights 8,271,555 8,271,555 Product development 208,518 208,518 Patents 994,000 994,000 Other 55,460 55,460 10,341,226 10,341,226 Less: accumulated amortization 8,710,096 8,485,253 Net 1,631,130 1,855,973 Other identifiable intangible assets - indefinite lived* 4,112,972 4,112,972 $ 5,744,102 $ 5,968,945 * Other identifiable intangible assets - indefinite lived consists of product formulations and the Company’s relationships with its distillers.
Schedule of Accumulated Amortization	Accumulated amortization consists of the following: September 30, 2018 March 31, 2018 Definite life brands $ 170,000 $ 170,000 Trademarks 421,836 403,617 Rights 7,122,925 6,954,303 Product development 52,748 47,880 Patents 942,587 909,453 Accumulated amortization $ 8,710,096 $ 8,485,253

Notes Payable (Tables)

Notes Payable (Tables)	6 Months Ended
	Sep. 30, 2018
Debt Disclosure [Abstract]
Schedule of Notes Payable and Credit Facility	NOTE 7 - NOTES PAYABLE September 30, 2018 March 31, 2018 Notes payable consist of the following: Foreign revolving credit facilities (A) $ 77,154 $ 126,148 Note payable - GCP note (B) 216,869 211,580 Credit facility (C) 22,182,692 18,505,897 5% Convertible notes (D) 50,000 50,000 11% Subordinated Note (E) 20,000,000 20,000,000 Total $ 42,599,085 $ 38,893,625 A. The Company has arranged various credit facilities aggregating €310,334 or $360,025 (translated at the September 30, 2018 exchange rate) and €310,324 or $382,279 (translated at the March 31, 2018 exchange rate) at September 30 and March 31, 2018, respectively, with an Irish bank, including overdraft coverage, creditors’ insurance, customs and excise guaranty, a revolving credit facility and Company credit cards. These credit facilities are payable on demand, continue until terminated by either party, are subject to annual review, and call for interest at the lender’s AA1 Rate minus 1.70%. At September 30 and March 31, 2018, there was €66,505 or $77,154 (translated at the September 30, 2018 exchange rate) and €102,404 or $126,148 (translated at the March 31, 2018 exchange rate) of principal due on the foreign revolving credit facilities included in current maturities of notes payable, respectively. B. In December 2009, GCP issued a promissory note (the “GCP Note”) in the aggregate principal amount of $211,580 to Gosling’s Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1, 2020, is payable at maturity, subject to certain acceleration events, and calls for annual interest of 5%, to be accrued and paid at maturity. At March 31, 2018, $10,579 of accrued interest was converted to amounts due to affiliates. At September 30, 2018, $216,869, consisting of $211,580 of principal and $5,289 of accrued interest, due on the GCP Note is included in long-term liabilities. At March 31, 2018, $211,580 of principal due on the GCP Note is included in long-term liabilities. C. In August 2011, the Company and CB-USA entered into a loan and security agreement (as amended and restated, and further amended, the “Amended Agreement”) with a third-party lender ACF FinCo I LP (“ACF,”) as successor in interest, which, as amended, provided for availability (subject to certain terms and conditions) of a facility of up to $21.0 million (the “Credit Facility”) for the purpose of providing the Company with working capital., including a sublimit in the maximum principal amount of $7,000,000 to permit the Company to acquire aged whiskey inventory (the “Purchased Inventory Sublimit”) subject to certain conditions set forth in the Amended Agreement. The Company and CB-USA are referred to individually and collectively as the Borrower. Pursuant to the Loan Agreement Amendment, the Company and CB-USA may borrow up to the lesser of (x) $21,000,000 and (y) the sum of the borrowing base calculated in accordance with the Amended Agreement and the Purchased Inventory Sublimit. In May 2018, the Company and CB-USA entered into a Fourth Amendment (the “Fourth Amendment”) to the Amended Agreement to amend certain terms of the Credit Facility. Among other changes, the Fourth Amendment increased the maximum amount of the Credit Facility from $21,000,000 to $23,000,000, and amended the definition of borrowing base to increase the amount of borrowing that can be collateralized by inventory. The Credit Facility interest rate is the rate that, when annualized, is the greatest of (a) the Prime Rate plus 3.00%, (b) the LIBOR Rate plus 5.50% and (c) 6.00%. As of September 30, 2018, the Credit Facility interest rate was 7.75%. The Purchased Inventory Sublimit interest rate is the rate that, when annualized, is the greatest of (a) the Prime Rate plus 4.25%, (b) the LIBOR Rate plus 6.75% and (c) 7.50%. As of September 30, 2018, the interest rate applicable to the Purchased Inventory Sublimit was 9.5%. The monthly facility fee is 0.75% per annum of the maximum Credit Facility. Also, the Company must pay a monthly facility fee of $2,000 with respect to the Purchased Inventory Sublimit until all obligations with respect thereof are fully paid and performed. The Amended Agreement contains EBITDA targets allowing for further interest rate reductions in the future. The Company and CB-USA are permitted to prepay the Credit Facility in whole or the Purchased Inventory Sublimit, in whole or in part, subject to certain prepayment penalties as set forth in the Loan Agreement Amendment. For the six months ended September 30, 2018, the Company paid interest at 7.31175% through April 30, 2018, then 7.35805% through May 31, 2018, then 7.30031% through June 30, 2018, then 7.5% through September 27, 2018, then 7.75% through September 30, 2018 on the Amended Agreement. For the six months ended September 30, 2017, the Company paid interest at 6.5% through June 14, 2017, then 6.75% through September 30, 2017 on the Amended Agreement. For the six months ended September 30, 2018, the Company paid interest at 9.06175% through April 30, 2018, then 9.10805% through May 31, 2018, then 9.05031% through June 30, 2018, then 9.25% through September 27, 2018, then 9.5% through September 30, 2018 on the Purchased Inventory Sublimit. For the six months ended September 30, 2017, the Company paid interest at 8.25% through June 14, 2017, and then at 8.5% through September 30, 2017 on the Purchased Inventory Sublimit. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Credit Facility. After the occurrence and during the continuance of any “Default” or “Event of Default” (as defined under the Amended Agreement), the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Credit Facility interest rate. There have been no Events of Default under the Credit Facility. ACF also receives a collateral management fee of $1,000 per month (increased to $2,000 after the occurrence of and during the continuance of an Event of Default) in addition to the facility fee with respect to the Purchased Inventory Sublimit. The Amended Agreement contains standard borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The Amended Agreement includes negative covenants that, among other things, restrict the Borrower’s ability to create additional indebtedness, dispose of properties, incur liens and make distributions or cash dividends. The obligations of the Borrower under the Amended Amendment are secured by the grant of a pledge and security interest in all of the assets of the Borrower. At September 30, 2018, the Company was in compliance, in all respects, with the covenants under the Amended Agreement. The Credit Facility matures on July 31, 2020. ACF required as a condition to entering into an amendment to the Amended Agreement in August 2015 that ACF enter into a participation agreement with certain related parties of the Company, including Frost Gamma Investments Trust, an entity affiliated with Phillip Frost, M.D., a director and principal shareholder of the Company, Mark E. Andrews, III, a director of the Company and the Company’s Chairman, Richard J. Lampen, a director of the Company and the Company’s President and Chief Executive Officer, Brian L. Heller, the Company’s General Counsel and Assistant Secretary, and Alfred J. Small, the Company’s Senior Vice President, Chief Financial Officer, Treasurer and Secretary, to allow for the sale of participation interests in the Purchased Inventory Sublimit and the inventory purchased with the proceeds thereof. The participation agreement provides that ACF’s commitment to fund each advance of the Purchased Inventory Sublimit shall be limited to seventy percent (70%), up to an aggregate maximum principal amount for all advances equal to $4,900,000. Neither the Company nor CB-USA is a party to the participation agreement. However, the Company and CB-USA are party to a fee letter with the junior participants (including the related party junior participants) pursuant to which the Company and CB-USA were obligated to pay the junior participants a closing fee of $18,000 on the effective date of the Loan Agreement Amendment and are obligated to pay a commitment fee of $18,000 on each anniversary of the effective date until the junior participants’ obligations are terminated pursuant to the participation agreement. In August 2015, the Company used $3,000,000 of the Purchased Inventory Sublimit to acquire aged bourbon inventory. Frost Gamma Investments Trust ($150,000), Mark E. Andrews, III ($50,000), Richard J. Lampen ($100,000), Brian L. Heller ($42,500) and Alfred J. Small ($15,000) each acquired participation interests in the Purchased Inventory Sublimit and the inventory purchased with the proceeds thereof. In January 2017, the Company acquired $1,030,000 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($51,500), Richard J. Lampen ($34,333), Mark E. Andrews, III ($17,167), Brian L. Heller ($14,592), and Alfred J. Small ($5,150), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In October 2017, the Company acquired $1,308,125 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($65,406), Richard J. Lampen ($43,604), Mark E. Andrews, III ($21,802), Brian L. Heller ($18,532), and Alfred J. Small ($6,541), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In December 2017, the Company acquired $900,425 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($45,021), Richard J. Lampen ($30,014), Mark E. Andrews, III ($15,007), Brian L. Heller ($12,756), and Alfred J. Small ($4,502), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In April 2018, the Company acquired $2,001,000 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($100,050), Richard J. Lampen ($66,700), Mark E. Andrews, III ($33,350), Brian L. Heller ($28,348), and Alfred J. Small ($10,005), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In June 2018, the Company acquired $1,035,000 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($51,750), Richard J. Lampen ($34,500), Mark E. Andrews, III ($17,250), Brian L. Heller ($14,663), and Alfred J. Small ($5,175), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. Under the terms of the participation agreement, the participants receive interest at the rate of 11% per annum. At September 30 and March 31, 2018, $22,255,062 and $18,604,962, respectively, due on the Credit Facility was included in long-term liabilities. At September 30 and March 31, 2018, there was $744,938 and $2,395,038, respectively, in potential availability under the Credit Facility. In connection with the adoption of ASU 2015-03, the Company included $72,370 and $99,065 of debt issuance costs at September 30 and March 31, 2018, respectively, as direct deductions from the carrying amount of the related debt liability. In October 2018, the Company and CB-USA entered into a Fifth Amendment (the “Fifth Amendment”) to the Amended Agreement to amend certain terms of the Company’s existing Credit Facility with ACF. Among other changes, the Fifth Amendment increased the maximum amount of the Credit Facility from $23,000,000 to $25,000,000, and amended the definition of borrowing base to increase the amount of borrowing that can be collateralized by inventory. The Company and CB-USA paid ACF an aggregate $50,000 commitment fee in connection with the Amendment. In connection with the Amendment, the Company and CB-USA also entered into an Amended and Restated Revolving Credit Note. In November 2018, the Company and CB-USA entered into a Sixth Amendment (the “Sixth Amendment”) to the Amended Agreement to amend certain terms of the Company’s existing Credit Facility with ACF. Among other changes, the Sixth Amendment extends the term of the Credit Facility to July 31, 2020 and amended the definition of borrowing base to increase the amount of borrowing that can be collateralized by inventory. The Company and CB-USA paid ACF an aggregate $57,500 commitment fee in connection with the Amendment. D. In October 2013, the Company entered into a 5% Convertible Subordinated Note Purchase Agreement (the “Note Purchase Agreement”) with the purchasers party thereto, under which the Company issued an aggregate initial principal amount of $2,125,000 of unsecured subordinated notes (the “Convertible Notes”). The Convertible Notes bear interest at a rate of 5% per annum, payable quarterly, until their maturity date of December 15, 2018. The Convertible Notes, and accrued but unpaid interest thereon, are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Company’s common stock at a conversion price of $0.90 per share (the “Conversion Price”). The Convertible Notes may be prepaid in whole or in part at any time without penalty or premium, but with payment of accrued interest to the date of prepayment. The Convertible Notes contain customary events of default, which, if uncured, entitle each note holder to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the Convertible Notes. The purchasers of the Convertible Notes included related parties of the Company, including an affiliate of Dr. Phillip Frost ($500,000), Mark E. Andrews, III ($50,000), an affiliate of Richard J. Lampen ($50,000), an affiliate of Glenn Halpryn ($200,000), Dennis Scholl ($100,000), and Vector Group Ltd., a more than 5% shareholder of ours, of which Richard Lampen is an executive officer, Henry Beinstein, a director of ours, is a director and Phillip Frost, M.D. is a principal shareholder ($200,000). The Company may forcibly convert all or any part of the Convertible Notes and all accrued but unpaid interest thereon if (i) the average daily volume of the Company’s common stock (as reported on the principal market or exchange on which the common stock is listed or quoted for trading) exceeds $50,000 per trading day and (ii) the volume weighted average price of the common stock for at least twenty (20) trading days during any thirty (30) consecutive trading day period exceeds 250% of the then-current Conversion Price. Any forced conversion will be applied ratably to the holders of all Convertible Notes issued pursuant to the Note Purchase Agreement based on each holder’s then-current note holdings. In connection with the Note Purchase Agreement, each purchaser of the Convertible Notes was required to execute a joinder to the subordination agreement, by and among ACF and certain other junior lenders to the Company; the Company is not a party to the subordination agreement. During the year ended March 31, 2018, certain holders of the Convertible Notes converted an aggregate $1,632,000 of the outstanding principal and interest balances of their Convertible Notes into 1,813,334 shares of the Company’s common stock, pursuant to the terms of the Convertible Notes. The converting holders included an affiliate of Dr. Phillip Frost, Mark E. Andrews, III an affiliate of Richard J. Lampen, and Vector Group Ltd. At each of September 30 and March 31, 2018, $50,000 of principal due on the Convertible Notes was included in current maturities of notes payable. E. In March 2017, the Company issued a promissory note to Frost Nevada Investments Trust (the “Holder”), an entity affiliated with Phillip Frost, M.D., in the aggregate principal amount of $20,000,000 (the “Subordinated Note”). The purpose of Company’s issuance of the Subordinated Note was to finance the GCP Share Acquisition. The Subordinated Note bears interest quarterly at the rate of 11% per annum. All claims of the Holder to principal, interest and any other amounts owed under the Subordinated Note are subordinated in right of payment to all indebtedness of the Company existing as of the date of the Subordinated Note. The Subordinated Note contains customary events of default and may be prepaid by the Company, in whole or in part, without penalty, at any time. In April 2018, the Company entered into a First Amendment to the Subordinated Note to extend the maturity date on the Subordinated Note from March 15, 2019 until September 15, 2020. No other provisions of the Subordinated Note were amended.

Geographic Information (Tables)

Geographic Information (Tables)	6 Months Ended
	Sep. 30, 2018
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	The following table sets forth the amounts and percentage of consolidated sales, net, consolidated income from operations, consolidated net loss attributable to common shareholders, consolidated income tax expense and consolidated assets from the U.S. and foreign countries and consolidated sales, net by category. Three months ended September 30, 2018 2017 Consolidated Sales, net: International $ 2,237,418 9.6 % $ 2,177,367 10.4 % U.S. - control states 4,519,667 21.4 % 4,365,492 23.3 % U.S. - open states 16,553,078 78.6 % 14,351,291 76.7 % United States 21,072,745 90.4 % 18,716,783 89.6 % Total Consolidated Sales, net $ 23,310,163 100.0 % $ 20,894,150 100.0 % Consolidated Income from Operations: International $ 24,211 2.3 % $ 15,737 1.4 % United States 1,024,228 97.7 % 1,143,139 98.6 % Total Consolidated Income from Operations $ 1,048,439 100.0 % $ 1,158,876 100.0 % Consolidated Net Income (Loss) Attributable to Common Shareholders: International $ 48,135 22.3 % $ 47,470 2,822.9 % United States (264,271 ) (122.3 )% (49,151 ) (2,922.9 )% Total Consolidated Net Loss Attributable to Common Shareholders $ (216,136 ) 100.0 % $ (1,681 ) 100.0 % Income tax expense, net: United States $ 217 100.0 % $ 25,335 100.0 % Consolidated Sales, net by category: Whiskey $ 9,000,528 38.6 % $ 7,335,290 35.2 % Rum 4,176,749 17.9 % $ 4,168,262 19.9 % Liqueurs 2,536,745 10.9 % 2,579,437 12.3 % Vodka 336,166 1.4 % 353,792 1.7 % Tequila 26,479 0.1 % 84,560 0.4 % Ginger beer 7,235,923 31.0 % 6,372,809 30.5 % Total Consolidated Sales, net $ 23,310,163 100.0 % $ 20,894,150 100.0 % Six months ended September 30, 2018 2017 Consolidated Sales, net: International $ 4,544,236 9.8 % $ 4,442,146 10.6 % U.S. - control states 9,831,306 23.5 % 8,644,802 23.2 % U.S. - open states 32,039,009 76.5 % 28,659,489 76.8 % United States 41,870,315 91.2 % 37,304,291 89.4 % Total Consolidated Sales, net $ 46,414,551 100.0 % $ 41,746,437 100.0 % Consolidated (Loss) Income from Operations: International $ (53,695 ) (3.1 )% $ (13,261 ) (1.1 )% United States 1,786,738 103.1 % 1,226,608 101.1 % Total Consolidated Income from Operations $ 1,733,043 100.0 % $ 1,213,347 100.0 % Consolidated Net (Loss) Income Attributable to Common Shareholders: International $ (867 ) 0.1 % $ 42,262 4.5 % United States (905,976 ) 99.9 % (990,340 ) (104.5 )% Total Consolidated Net Loss Attributable to Common Shareholders $ (906,843 ) 100.0 % $ (948,078 ) 100.0 % Income tax expense, net: United States $ (17,898 ) 100.0 % $ (43,748 ) 100.0 % Consolidated Sales, net by category: Whiskey $ 19,141,660 39.8 % $ 14,505,777 34.8 % Rum 8,733,772 18.8 % $ 8,621,765 20.7 % Liqueurs 4,523,841 9.7 % 4,638,346 11.1 % Vodka 656,744 1.4 % 643,255 1.5 % Tequila 85,162 0.2 % 129,736 0.3 % Ginger beer 13,932,543 30.0 % 13,207,558 31.6 % Total Consolidated Sales, net $ 46,414,551 100.0 % $ 41,746,437 100.0 % As of September 30, 2018 As of March 31, 2018 Consolidated Assets: International $ 2,501,001 3.8 % $ 2,886,735 4.8 % United States 62,905,365 96.2 % 57,446,625 95.2 % Total Consolidated Assets $ 65,406,366 100.0 % $ 60,333,360 100.0 %

Organization and Summary of S_3

Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2018	Mar. 31, 2018
Income tax reconciliation description	The 2017 Tax Act includes a number of changes to existing U.S. tax laws that impact the Company, most notably a reduction of the U.S. corporate income tax rate from 35 percent to 21 percent for tax years beginning after December 31, 2017.
Effective income tax rate	21.00%
Uncertain tax related to interest and penalties	$ 6,778	$ 6,778
2017 Tax Act [Member]
Income tax reconciliation description	The 2017 Tax Act reduced the U.S. federal corporate tax rate from 35.0% to 21.0% for all corporations effective January 1, 2018.
U.S. Federal Corporate Tax [Member]
Income tax reconciliation description	For fiscal year companies, the change in law requires the application of a blended rate for each quarter of the fiscal year, which in the Company's case is 30.79% for the fiscal year ended March 31, 2018. Thereafter, the applicable statutory rate is 21.0%.
Effective income tax rate	30.79%
November 2018 [Member] | Loan and Security Agreement [Member]
Debt maturity date	Jul. 31, 2020
Gosling-Castle Partners Inc [Member]
Equity method investee, cumulative percentage of ownership interest	80.10%

Basic and Diluted Net Loss Pe_3

Basic and Diluted Net Loss Per Common Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Common shares not included in calculating diluted net loss per share	16,224,748	18,448,341
Stock Options [Member]
Common shares not included in calculating diluted net loss per share	14,171,442	15,523,008
Unvested Restricted Shares [Member]
Common shares not included in calculating diluted net loss per share	1,997,750	1,092,000
5% Convertible Notes [Member]
Common shares not included in calculating diluted net loss per share	55,556	1,833,333

Basic and Diluted Net Loss Pe_4

Basic and Diluted Net Loss Per Common Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) (Parenthetical)	3 Months Ended		6 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2017
Earnings Per Share [Abstract]
Conversion of convertible notes, percent	5.00%	5.00%	5.00%

Inventories (Details Narrative)

Inventories (Details Narrative) - USD ($)	Sep. 30, 2018	Mar. 31, 2018
Inventory Disclosure [Abstract]
Percentage of raw materials located outside united states	6.00%	9.00%
Percentage of finished goods located outside united states	6.00%	3.00%
Payments to acquire inventory	$ 7,490,366

Inventories - Schedule of Inven

Inventories - Schedule of Inventory (Details) - USD ($)	Sep. 30, 2018	Mar. 31, 2018
Inventory Disclosure [Abstract]
Raw materials	$ 25,080,981	$ 21,015,172
Finished goods - net	15,523,731	13,540,381
Total	$ 40,604,712	$ 34,555,553

Equity Investment (Details Narr

Equity Investment (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended
	Mar. 31, 2017	Jun. 30, 2015	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Mar. 31, 2018
Net income (loss) attributable to noncontrolling interest			$ 214,812	$ 282,303	$ 598,153	$ 363,482
Stockholders equity attributable to noncontrolling interest			4,166,789		4,166,789		$ 3,568,636
Income loss from equity method investments			55,113	29,846	89,141	71,595
Investment in non-consolidated affiliate equity			903,067		903,067		813,926
Gosling-Castle Partners Inc [Member]
Number of stock issued during period acquisitions, shares	201,000
Equity method interest, percentage	20.10%
Payments to acquire businesses, cash	$ 20,000,000
Number of common stock shares issued	1,800,000
Income (loss) from subsidiaries, before tax			1,415,600	1,425,534	3,341,936	1,851,541
Net income (loss) attributable to noncontrolling interest			281,704	$ 283,681	665,045	$ 368,457
Stockholders equity attributable to noncontrolling interest			4,166,789		4,166,789		3,568,636
Gosling-Castle Partners Inc [Member] | Maximum [Member]
Equity method interest, percentage	80.10%
Copperhead Distillery Company [Member]
Equity method interest, percentage		20.00%		5.00%		5.00%
Payment to acquire finished goods		$ 500,000
Income loss from equity method investments			55,113	$ 29,846	89,141	$ 71,595
Investment in non-consolidated affiliate equity			$ 903,067		$ 903,067		$ 813,926
Copperhead Distillery Company [Member] | Existing Shareholder [Member]
Due from related parties				$ 156,000		$ 156,000

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details Narrative) - USD ($)	Sep. 30, 2018	Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 496,226	$ 496,226

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) - USD ($)		Sep. 30, 2018	Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Definite life brands		$ 170,000	$ 170,000
Trademarks		641,693	641,693
Rights		8,271,555	8,271,555
Product development		208,518	208,518
Patents		994,000	994,000
Other		55,460	55,460
Finite-Lived Intangible Assets, Gross		10,341,226	10,341,226
Less: accumulated amortization		8,710,096	8,485,253
Net		1,631,130	1,855,973
Other identifiable intangible assets - indefinite lived	[1]	4,112,972	4,112,972
Total intangible assets, net		$ 5,744,102	$ 5,968,945
[1]	Other identifiable intangible assets - indefinite lived consists of product formulations and the Company's relationships with its distillers.

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of Accumulated Amortization (Details) - USD ($)	Sep. 30, 2018	Mar. 31, 2018
Accumulated amortization	$ 8,710,096	$ 8,485,253
Definite Life Brands [Member]
Accumulated amortization	170,000	170,000
Trademarks [Member]
Accumulated amortization	421,836	403,617
Rights [Member]
Accumulated amortization	7,122,925	6,954,303
Product Development [Member]
Accumulated amortization	52,748	47,880
Patents [Member]
Accumulated amortization	$ 942,587	$ 909,453

Restricted Cash (Details Narrat

Restricted Cash (Details Narrative)	Sep. 30, 2018USD ($)	Sep. 30, 2018EUR (€)	Mar. 31, 2018USD ($)	Mar. 31, 2018EUR (€)
Restricted cash | $	$ 360,025		$ 382,279
Euro [Member]
Restricted cash | €		€ 310,334		€ 310,324

Notes Payable - Schedule of Not

Notes Payable - Schedule of Notes Payable and Credit Facility (Details) - USD ($)		Sep. 30, 2018	Mar. 31, 2018
Notes payable and credit facility		$ 42,599,085	$ 38,893,625
Note Payable - GCP Note [Member]
Notes payable and credit facility	[1]	216,869	211,580
5% Convertible Notes [Member]
Notes payable and credit facility	[2]	50,000	50,000
11% Subordinated Note [Member]
Notes payable and credit facility	[3]	20,000,000	20,000,000
Foreign Revolving Credit Facilities [Member]
Notes payable and credit facility	[4]	77,154	126,148
Credit Facility [Member]
Notes payable and credit facility	[5]	$ 22,182,692	$ 18,505,897
[1]	In December 2009, GCP issued a promissory note ("the GCP Note") in the aggregate principal amount of $211,580 to Goslings' Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1, 2020, is payable at maturity, subject to certain acceleration events, and calls for annual interest of 5%, to be accrued and paid at maturity. At March 31, 2018, $10,579 of accrued interest was converted to amounts due to affiliates. At September 30, 2018, $216,869, consisting of $211,580 of principal and $5,289 of accrued interest, due on the GCP Note is included in long-term liabilities. At March 31, 2018, $211,580 of principal due on the GCP Note is included in long-term liabilities.
[2]	In October 2013, the Company entered into a 5% Convertible Subordinated Note Purchase Agreement (the “Note Purchase Agreement”) with the purchasers party thereto, under which the Company issued an aggregate initial principal amount of $2,125,000 of unsecured subordinated notes (the “Convertible Notes”). The Convertible Notes bear interest at a rate of 5% per annum, payable quarterly, until their maturity date of December 15, 2018. The Convertible Notes, and accrued but unpaid interest thereon, are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Company’s common stock at a conversion price of $0.90 per share (the “Conversion Price”). The Convertible Notes may be prepaid in whole or in part at any time without penalty or premium, but with payment of accrued interest to the date of prepayment. The Convertible Notes contain customary events of default, which, if uncured, entitle each note holder to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the Convertible Notes. The purchasers of the Convertible Notes included related parties of the Company, including an affiliate of Dr. Phillip Frost ($500,000), Mark E. Andrews, III ($50,000), an affiliate of Richard J. Lampen ($50,000), an affiliate of Glenn Halpryn ($200,000), Dennis Scholl ($100,000), and Vector Group Ltd., a more than 5% shareholder of ours, of which Richard Lampen is an executive officer, Henry Beinstein, a director of ours, is a director and Phillip Frost, M.D. is a principal shareholder ($200,000). The Company may forcibly convert all or any part of the Convertible Notes and all accrued but unpaid interest thereon if (i) the average daily volume of the Company’s common stock (as reported on the principal market or exchange on which the common stock is listed or quoted for trading) exceeds $50,000 per trading day and (ii) the volume weighted average price of the common stock for at least twenty (20) trading days during any thirty (30) consecutive trading day period exceeds 250% of the then-current Conversion Price. Any forced conversion will be applied ratably to the holders of all Convertible Notes issued pursuant to the Note Purchase Agreement based on each holder’s then-current note holdings. In connection with the Note Purchase Agreement, each purchaser of the Convertible Notes was required to execute a joinder to the subordination agreement, by and among ACF and certain other junior lenders to the Company; the Company is not a party to the subordination agreement. During the year ended March 31, 2018, certain holders of the Convertible Notes converted an aggregate $1,632,000 of the outstanding principal and interest balances of their Convertible Notes into 1,813,334 shares of the Company’s common stock, pursuant to the terms of the Convertible Notes. The converting holders included an affiliate of Dr. Phillip Frost, Mark E. Andrews, III an affiliate of Richard J. Lampen, and Vector Group Ltd. At each of September 30 and March 31, 2018, $50,000 of principal due on the Convertible Notes was included in current maturities of notes payable.
[3]	In March 2017, the Company issued a promissory note to Frost Nevada Investments Trust (the "Holder"), an entity affiliated with Phillip Frost, M.D., in the aggregate principal amount of $20,000,000 (the "Subordinated Note"). The purpose of Company's issuance of the Subordinated Note was to finance the GCP Share Acquisition. The Subordinated Note bears interest quarterly at the rate of 11% per annum. All claims of the Holder to principal, interest and any other amounts owed under the Subordinated Note are subordinated in right of payment to all indebtedness of the Company existing as of the date of the Subordinated Note. The Subordinated Note contains customary events of default and may be prepaid by the Company, in whole or in part, without penalty, at any time. In April 2018, the Company entered into a First Amendment to the Subordinated Note to extend the maturity date on the Subordinated Note from March 15, 2019 until September 15, 2020. No other provisions of the Subordinated Note were amended
[4]	The Company has arranged various credit facilities aggregating €310,334 or $360,025 (translated at the September 30, 2018 exchange rate) and €310,324 or $382,279 (translated at the March 31, 2018 exchange rate) at September 30 and March 31, 2018, respectively, with an Irish bank, including overdraft coverage, creditors' insurance, customs and excise guaranty, a revolving credit facility and Company credit cards. These credit facilities are payable on demand, continue until terminated by either party, are subject to annual review, and call for interest at the lenders' AA1 Rate minus 1.70%. At September 30 and March 31, 2018, there was €66,505 or $77,154 (translated at the September 30, 2018 exchange rate) and €102,404 or $126,148 (translated at the March 31, 2018 exchange rate) of principal due on the foreign revolving credit facilities included in current maturities of notes payable, respectively.
[5]	In August 2011, the Company and CB-USA entered into a loan and security agreement (as amended and restated, and further amended, the “Amended Agreement”) with a third-party lender ACF FinCo I LP (“ACF,”) as successor in interest, which, as amended, provided for availability (subject to certain terms and conditions) of a facility of up to $21.0 million (the “Credit Facility”) for the purpose of providing the Company with working capital., including a sublimit in the maximum principal amount of $7,000,000 to permit the Company to acquire aged whiskey inventory (the “Purchased Inventory Sublimit”) subject to certain conditions set forth in the Amended Agreement. The Company and CB-USA are referred to individually and collectively as the Borrower. Pursuant to the Loan Agreement Amendment, the Company and CB-USA may borrow up to the lesser of (x) $21,000,000 and (y) the sum of the borrowing base calculated in accordance with the Amended Agreement and the Purchased Inventory Sublimit. In May 2018, the Company and CB-USA entered into a Fourth Amendment (the “Fourth Amendment”) to the Amended Agreement to amend certain terms of the Credit Facility. Among other changes, the Fourth Amendment increased the maximum amount of the Credit Facility from $21,000,000 to $23,000,000, and amended the definition of borrowing base to increase the amount of borrowing that can be collateralized by inventory.The Credit Facility interest rate is the rate that, when annualized, is the greatest of (a) the Prime Rate plus 3.00%, (b) the LIBOR Rate plus 5.50% and (c) 6.00%. As of September 30, 2018, the Credit Facility interest rate was 7.75%. The Purchased Inventory Sublimit interest rate is the rate that, when annualized, is the greatest of (a) the Prime Rate plus 4.25%, (b) the LIBOR Rate plus 6.75% and (c) 7.50%. As of September 30, 2018, the interest rate applicable to the Purchased Inventory Sublimit was 9.5%. The monthly facility fee is 0.75% per annum of the maximum Credit Facility. Also, the Company must pay a monthly facility fee of $2,000 with respect to the Purchased Inventory Sublimit until all obligations with respect thereof are fully paid and performed. The Amended Agreement contains EBITDA targets allowing for further interest rate reductions in the future. The Company and CB-USA are permitted to prepay the Credit Facility in whole or the Purchased Inventory Sublimit, in whole or in part, subject to certain prepayment penalties as set forth in the Loan Agreement Amendment. For the six months ended September 30, 2018, the Company paid interest at 7.31175% through April 30, 2018, then 7.35805% through May 31, 2018, then 7.30031% through June 30, 2018, then 7.5% through September 27, 2018, then 7.75% through September 30, 2018 on the Amended Agreement. For the six months ended September 30, 2017, the Company paid interest at 6.5% through June 14, 2017, then 6.75% through September 30, 2017 on the Amended Agreement. For the six months ended September 30, 2018, the Company paid interest at 9.06175% through April 30, 2018, then 9.10805% through May 31, 2018, then 9.05031% through June 30, 2018, then 9.25% through September 27, 2018, then 9.5% through September 30, 2018 on the Purchased Inventory Sublimit. For the six months ended September 30, 2017, the Company paid interest at 8.25% through June 14, 2017, and then at 8.5% through September 30, 2017 on the Purchased Inventory Sublimit. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Credit Facility. After the occurrence and during the continuance of any “Default” or “Event of Default” (as defined under the Amended Agreement), the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Credit Facility interest rate. There have been no Events of Default under the Credit Facility. ACF also receives a collateral management fee of $1,000 per month (increased to $2,000 after the occurrence of and during the continuance of an Event of Default) in addition to the facility fee with respect to the Purchased Inventory Sublimit. The Amended Agreement contains standard borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The Amended Agreement includes negative covenants that, among other things, restrict the Borrower’s ability to create additional indebtedness, dispose of properties, incur liens and make distributions or cash dividends. The obligations of the Borrower under the Amended Amendment are secured by the grant of a pledge and security interest in all of the assets of the Borrower. At September 30, 2018, the Company was in compliance, in all respects, with the covenants under the Amended Agreement. The Credit Facility matures on July 31, 2020. ACF required as a condition to entering into an amendment to the Amended Agreement in August 2015 that ACF enter into a participation agreement with certain related parties of the Company, including Frost Gamma Investments Trust, an entity affiliated with Phillip Frost, M.D., a director and principal shareholder of the Company, Mark E. Andrews, III, a director of the Company and the Company’s Chairman, Richard J. Lampen, a director of the Company and the Company’s President and Chief Executive Officer, Brian L. Heller, the Company’s General Counsel and Assistant Secretary, and Alfred J. Small, the Company’s Senior Vice President, Chief Financial Officer, Treasurer and Secretary, to allow for the sale of participation interests in the Purchased Inventory Sublimit and the inventory purchased with the proceeds thereof. The participation agreement provides that ACF’s commitment to fund each advance of the Purchased Inventory Sublimit shall be limited to seventy percent (70%), up to an aggregate maximum principal amount for all advances equal to $4,900,000. Neither the Company nor CB-USA is a party to the participation agreement. However, the Company and CB-USA are party to a fee letter with the junior participants (including the related party junior participants) pursuant to which the Company and CB-USA were obligated to pay the junior participants a closing fee of $18,000 on the effective date of the Loan Agreement Amendment and are obligated to pay a commitment fee of $18,000 on each anniversary of the effective date until the junior participants’ obligations are terminated pursuant to the participation agreement. In August 2015, the Company used $3,000,000 of the Purchased Inventory Sublimit to acquire aged bourbon inventory. Frost Gamma Investments Trust ($150,000), Mark E. Andrews, III ($50,000), Richard J. Lampen ($100,000), Brian L. Heller ($42,500) and Alfred J. Small ($15,000) each acquired participation interests in the Purchased Inventory Sublimit and the inventory purchased with the proceeds thereof. In January 2017, the Company acquired $1,030,000 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($51,500), Richard J. Lampen ($34,333), Mark E. Andrews, III ($17,167), Brian L. Heller ($14,592), and Alfred J. Small ($5,150), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In October 2017, the Company acquired $1,308,125 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($65,406), Richard J. Lampen ($43,604), Mark E. Andrews, III ($21,802), Brian L. Heller ($18,532), and Alfred J. Small ($6,541), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In December 2017, the Company acquired $900,425 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($45,021), Richard J. Lampen ($30,014), Mark E. Andrews, III ($15,007), Brian L. Heller ($12,756), and Alfred J. Small ($4,502), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In April 2018, the Company acquired $2,001,000 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($100,050), Richard J. Lampen ($66,700), Mark E. Andrews, III ($33,350), Brian L. Heller ($28,348), and Alfred J. Small ($10,005), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. In June 2018, the Company acquired $1,035,000 in aged bulk bourbon under the Purchased Inventory Sublimit with additional borrowings from certain related parties of the Company, including Frost Gamma Investments Trust ($51,750), Richard J. Lampen ($34,500), Mark E. Andrews, III ($17,250), Brian L. Heller ($14,663), and Alfred J. Small ($5,175), as junior participants in the Purchased Inventory Sublimit with respect to such purchase. Under the terms of the participation agreement, the participants receive interest at the rate of 11% per annum. At September 30 and March 31, 2018, $22,255,062 and $18,604,962, respectively, due on the Credit Facility was included in long-term liabilities. At September 30 and March 31, 2018, there was $744,938 and $2,395,038, respectively, in potential availability under the Credit Facility. In connection with the adoption of ASU 2015-03, the Company included $72,370 and $99,065 of debt issuance costs at September 30 and March 31, 2018, respectively, as direct deductions from the carrying amount of the related debt liability. In October 2018, the Company and CB-USA entered into a Fifth Amendment (the “Fifth Amendment”) to the Amended Agreement to amend certain terms of the Company’s existing Credit Facility with ACF. Among other changes, the Fifth Amendment increased the maximum amount of the Credit Facility from $23,000,000 to $25,000,000, and amended the definition of borrowing base to increase the amount of borrowing that can be collateralized by inventory. The Company and CB-USA paid ACF an aggregate $50,000 commitment fee in connection with the Amendment. In connection with the Amendment, the Company and CB-USA also entered into an Amended and Restated Revolving Credit Note. In November 2018, the Company and CB-USA entered into a Sixth Amendment (the “Sixth Amendment”) to the Amended Agreement to amend certain terms of the Company’s existing Credit Facility with ACF. Among other changes, the Sixth Amendment extends the term of the Credit Facility to July 31, 2020 and amended the definition of borrowing base to increase the amount of borrowing that can be collateralized by inventory. The Company and CB-USA paid ACF an aggregate $57,500 commitment fee in connection with the Amendment.

Notes Payable - Schedule of N_2

Notes Payable - Schedule of Notes Payable and Credit Facility (Details) (Parenthetical)	Sep. 30, 2018USD ($)	Sep. 27, 2018	Jun. 30, 2018USD ($)	May 31, 2018USD ($)	May 31, 2018USD ($)	Apr. 30, 2018USD ($)	Jun. 14, 2017	Oct. 31, 2013USD ($)$ / shares	Apr. 30, 2018USD ($)	Aug. 31, 2015USD ($)	Oct. 31, 2013USD ($)$ / shares	Aug. 31, 2011USD ($)	Dec. 31, 2009USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2017	Sep. 30, 2018USD ($)	Sep. 30, 2017	Mar. 31, 2018USD ($)shares	Sep. 30, 2018EUR (€)	Mar. 31, 2018EUR (€)	Dec. 31, 2017USD ($)	Oct. 31, 2017USD ($)	Mar. 31, 2017USD ($)	Jan. 31, 2017USD ($)
Notes payable, current	$ 127,154													$ 127,154		$ 127,154		$ 176,148
Debt instrument, interest rate	5.00%													5.00%		5.00%			5.00%
Purchased inventory sublimit amount to acquire inventory										$ 3,000,000
Due to other related parties, current	$ 761,600													$ 761,600		$ 761,600		576,546
Payments to acquire inventory	7,490,366													7,490,366		7,490,366
Line of credit facility, remaining borrowing capacity	744,938													744,938		744,938		2,395,038
Debt issuance costs, net	72,370													72,370		72,370		99,065
Notes payable, noncurrent	216,869													$ 216,869		216,869		211,580
Debt conversion price percentage														5.00%	5.00%		5.00%
Convertible Notes [Member]
Debt instrument, convertible, if-converted value in excess of principal								$ 50,000
Debt conversion price percentage								250.00%
Debt converted into shares																		$ 1,632,000
Debt converted into shares, shares | shares																		1,813,334
Convertible promissory note principal amount	$ 50,000													$ 50,000		$ 50,000		$ 50,000
Frost Gamma Investments Trust [Member]
Due to other related parties, current										150,000											$ 45,021	$ 65,406		$ 51,500
Mark E. Andrews, III [Member]
Due to other related parties, current										50,000											15,007	21,802		17,167
Notes payable, noncurrent								$ 50,000			$ 50,000
Richard J. Lampen [Member]
Due to other related parties, current										100,000											30,014	43,604		34,333
Notes payable, noncurrent								50,000			50,000
Brian L. Heller [Member]
Due to other related parties, current										42,500											12,756	18,532		14,592
Alfred J. Small [Member]
Due to other related parties, current										$ 15,000											4,502	6,541		5,150
Dr. Phillip Frost [Member]
Notes payable, noncurrent								500,000			500,000
Glenn Halpryn [Member]
Notes payable, noncurrent								200,000			200,000
Dennis Scholl [Member]
Notes payable, noncurrent								100,000			100,000
Vector Group Ltd [Member]
Notes payable, noncurrent								$ 200,000			$ 200,000
Equity method interest, percentage								5.00%			5.00%
Frost Nevada Investments Trust [Member] | Phillip Frost [Member]
Debt instrument, interest rate																							11.00%
Convertible notes payable, noncurrent																							$ 20,000,000
Loan and Security Agreement [Member] | November 2018 [Member]
Debt instrument, maturity date																Jul. 31, 2020
Loan and Security Agreement [Member] | Maximum [Member]
Line of credit facility, maximum borrowing capacity												$ 21,000,000
Purchased Inventory Sublimit [Member]
Line of credit facility, interest rate during period																9.50%
Line of credit facility, interest rate description												(a) the Prime Rate plus 4.25%, (b) the LIBOR Rate plus 6.75% and (c) 7.50%.				The monthly facility fee is 0.75% per annum of the maximum Credit Facility
Percentage of monthly fee																0.75%
Monthly facility fee																$ 2,000
Debt instrument, interest rate during period	9.50%	9.25%	9.05031%		9.10805%	9.06175%	8.25%										8.50%
Payments to acquire inventory			$ 1,035,000			$ 2,001,000			$ 2,001,000												$ 900,425	$ 1,308,125		$ 1,030,000
Purchased Inventory Sublimit [Member] | Richard J. Lampen [Member]
Due to other related parties, current			34,500			66,700			66,700
Purchased Inventory Sublimit [Member] | Mark E. Andrews, III [Member]
Due to other related parties, current			17,250			33,350			33,350
Purchased Inventory Sublimit [Member] | Brian L. Heller [Member]
Due to other related parties, current			14,663			28,348			28,348
Purchased Inventory Sublimit [Member] | Alfred J. Small [Member]
Due to other related parties, current			5,175			10,005			10,005
Purchased Inventory Sublimit [Member] | Frost Gamma Investments Trust [Member]
Due to other related parties, current			$ 51,750			$ 100,050			$ 100,050
Purchased Inventory Sublimit [Member] | Maximum [Member]
Line of credit facility, maximum borrowing capacity												$ 7,000,000
Amended Agreement [Member]
Debt instrument, interest rate during period		7.50%	7.30031%	7.35805%		7.31175%	6.50%									7.75%	6.75%
Purchased inventory sublimit										Purchased Inventory Sublimit shall be limited to seventy percent (70%)
Proceeds from related party debt										$ 4,900,000
Closing fee payable										18,000
Commitment fee										$ 18,000
Participation Agreement [Member]
Debt instrument, interest rate	11.00%													11.00%		11.00%			11.00%
Fifth Amendment [Member] | October 2018 [Member]
Commitment fee																$ 50,000
Fifth Amendment [Member] | Maximum [Member] | October 2018 [Member]
Line of credit facility, borrowing capacity	$ 25,000,000													$ 25,000,000		25,000,000
Fifth Amendment [Member] | Minimum [Member] | October 2018 [Member]
Line of credit facility, borrowing capacity	23,000,000													23,000,000		$ 23,000,000
Sixth Amendment [Member] | November 2018 [Member]
Line of credit facility, expiration date																Jul. 31, 2020
Commitment fee																$ 57,500
Note Purchase Agreement [Member] | 5% Convertible Notes [Member]
Debt instrument, maturity date											Dec. 15, 2018
Debt instrument, interest rate								5.00%			5.00%
Unsecured debt								$ 2,125,000			$ 2,125,000
Debt instrument, convertible, conversion price | $ / shares								$ 0.90			$ 0.90
GCP Note [Member]
Debt instrument, periodic payment													$ 211,580			216,869
Debt instrument, maturity date													Apr. 1, 2020
Debt instrument, interest rate													5.00%
Debt instrument, accrued interest																5,289		10,579
Debt instrument, principal amount																211,580		211,580
Subordinated Note [Member]
Debt maturity description									In April 2018, the Company entered into a First Amendment to the Subordinated Note to extend the maturity date on the Subordinated Note from March 15, 2019 until September 15, 2020.
Irish Bank [Member]
Line of credit facility, maximum borrowing capacity	360,025													360,025		$ 360,025		382,279
Line of credit facility, interest rate during period																1.70%
Notes payable, current	77,154													77,154		$ 77,154		126,148
Irish Bank [Member] | Euro [Member]
Line of credit facility, maximum borrowing capacity | €																			€ 310,334	€ 310,324
Notes payable, current | €																			€ 66,505	€ 102,404
Credit Facility [Member]
Debt instrument, interest rate during period																3.25%
Annual facility fee receivables description																ACF also receives a collateral management fee of $1,000 per month (increased to $2,000 after the occurrence of and during the continuance of an Event of Default)
Line of credit facility, expiration date																Jul. 31, 2020
Long-term line of credit	$ 22,255,062													$ 22,255,062		$ 22,255,062		$ 18,604,962
Credit Facility [Member] | Loan and Security Agreement [Member]
Line of credit facility, interest rate during period																7.75%
Line of credit facility, interest rate description												(a) the Prime Rate plus 3.00%, (b) the LIBOR Rate plus 5.50% and (c) 6.00%.
Credit Facility [Member] | Loan and Security Agreement [Member] | Maximum [Member]
Line of credit facility, maximum borrowing capacity												$ 21,000,000
Credit Facility [Member] | Amended Agreement [Member] | Maximum [Member]
Line of credit facility, maximum borrowing capacity				$ 23,000,000	$ 23,000,000
Credit Facility [Member] | Amended Agreement [Member] | Minimum [Member]
Line of credit facility, maximum borrowing capacity				$ 21,000,000	$ 21,000,000

Equity (Details Narrative)

Equity (Details Narrative)	1 Months Ended
	Apr. 30, 2018shares
Restricted Stock [Member] | Directors Officers Employees and Related Parties [Member]
Number of stock option shares of common stock granted	1,100,000

Stock-Based Compensation (Detai

Stock-Based Compensation (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended			6 Months Ended
	Apr. 30, 2018	Sep. 30, 2018	Jun. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Number of restricted common stock granted, value
Share-based compensation		$ 497,219		$ 504,490	$ 987,704	$ 979,816
Unrecognized compensation cost		3,645,961			$ 3,645,961
Expected weighted average vesting period					1 year 10 months 28 days
Number of stock option shares exercised during the period					1,129,166	240,300
Restricted Stock [Member] | Employees, Directors and Consultants [Member]
Number of stock option shares of common stock granted	1,100,000
Percentage of vesting of share based compensation	25.00%
Number of restricted common stock granted, value	$ 1,342,000
Unvested Option [Member]
Unrecognized compensation cost		2,154,875			$ 2,154,875
Unvested Restricted Stock [Member]
Unrecognized compensation cost		$ 1,997,750			$ 1,997,750

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - 6 months ended Sep. 30, 2018	USD ($)	EUR (€)
New York [Member]
Lease expiration date	Feb. 29, 2020	Feb. 29, 2020
Operating leases, rent expense	$ 26,255
Dublin [Member]
Lease expiration date	Oct. 31, 2019	Oct. 31, 2019
Operating leases, rent expense	$ 1,740
Houston, TX [Member]
Lease expiration date	Jun. 26, 2021	Jun. 26, 2021
Operating leases, rent expense	$ 3,581
Newly Distilled Bourbon [Member]
Contract year ending	Dec. 31, 2018	Dec. 31, 2018
Long-term purchase commitment, amount	$ 3,900,000
Long term purchased amount	1,682,200
Euro [Member] | Dublin [Member]
Operating leases, rent expense | €		€ 1,500
Irish Whiskeys [Member] | Blended Irish Whiskeys [Member]
Long-term purchase commitment, amount	$ 331,202
Irish Whiskeys [Member] | Blended Irish Whiskeys [Member] | Euro [Member]
Long-term purchase commitment, amount | €		€ 285,489
Irish Whiskeys [Member] | Blended Irish Whiskeys [Member] | Four Contract Year [Member]
Long term purchase commitment percentage agreed to purchase	90.00%	90.00%
Contract year ending	Jun. 30, 2019	Jun. 30, 2019
Long-term purchase commitment, amount	$ 1,282,596
Irish Whiskeys [Member] | Blended Irish Whiskeys [Member] | Contract Year [Member] | Euro [Member]
Long-term purchase commitment, amount | €		€ 1,105,572
Irish Whiskeys [Member] | Single Malt Irish Whiskeys [Member]
Long-term purchase commitment, amount	$ 162,882
Irish Whiskeys [Member] | Single Malt Irish Whiskeys [Member] | Euro [Member]
Long-term purchase commitment, amount | €		€ 140,401
Irish Whiskeys [Member] | Single Malt Irish Whiskeys [Member] | Twelve Contract Year [Member]
Long term purchase commitment percentage agreed to purchase	80.00%	80.00%
Contract year ending	Jun. 30, 2019	Jun. 30, 2019
Long-term purchase commitment, amount	$ 667,987
Irish Whiskeys [Member] | Single Malt Irish Whiskeys [Member] | Twelve Contract Year [Member] | Euro [Member]
Long-term purchase commitment, amount | €		€ 575,791

Concentrations (Details Narrati

Concentrations (Details Narrative)	3 Months Ended		6 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Mar. 31, 2018
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Sales Revenue, Net [Member]
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]
Concentration risk, percentage	37.80%	36.30%	37.00%	38.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration risk, percentage			38.60%		35.90%

Geographic Information (Details

Geographic Information (Details Narrative)	6 Months Ended
	Sep. 30, 2018Number
Segment Reporting [Abstract]
Number of Reportable Segments	1

Geographic Information - Schedu

Geographic Information - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)		3 Months Ended		6 Months Ended
		Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Mar. 31, 2018
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net	[1]	$ 23,310,163	$ 20,894,150	$ 46,414,551	$ 41,746,437
Concentration Risk, Percentage		100.00%	100.00%	100.00%	100.00%
Total Consolidated Income from Operations		$ 1,048,439	$ 1,158,876	$ 1,733,043	$ 1,213,347
Consolidated Income from Operations, Percentage		100.00%	100.00%	100.00%	100.00%
Total Consolidated Net Loss Attributable to Common Shareholders:		$ (216,136)	$ (1,681)	$ (906,843)	$ (948,078)
Total Consolidated Net Loss Attributable to Common Shareholders: Percentage		100.00%	100.00%	100.00%	100.00%
Income tax expense, net		$ 217	$ (25,335)	$ (17,898)	$ (43,748)
Total Consolidated Assets		$ 65,406,225		$ 65,406,225		$ 60,333,360
Consolidated Assets Percentage		100.00%		100.00%		100.00%
Whiskey [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net		$ 9,000,528	7,335,290	$ 19,141,660	14,505,777
Rum [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net		4,176,749	4,168,262	8,733,772	8,621,765
Liqueur [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net		2,536,745	2,579,437	4,523,841	4,638,346
Vodka [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net		336,166	353,792	656,744	643,255
Tequila [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net		26,479	84,560	85,162	129,736
Ginger Beer [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net		7,235,923	6,372,809	13,932,543	13,207,558
Sales Revenue, Net [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net		$ 23,310,163	$ 20,894,150	$ 46,414,551	$ 41,746,437
Concentration Risk, Percentage		100.00%	100.00%	100.00%	100.00%
Sales Revenue, Net [Member] | Whiskey [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration Risk, Percentage		38.60%	35.20%	39.80%	34.80%
Sales Revenue, Net [Member] | Rum [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration Risk, Percentage		17.90%	19.90%	18.80%	20.70%
Sales Revenue, Net [Member] | Liqueur [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration Risk, Percentage		10.90%	12.30%	9.70%	11.10%
Sales Revenue, Net [Member] | Vodka [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration Risk, Percentage		1.40%	1.70%	1.40%	1.50%
Sales Revenue, Net [Member] | Tequila [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration Risk, Percentage		0.10%	0.40%	0.20%	0.30%
Sales Revenue, Net [Member] | Ginger Beer [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration Risk, Percentage		31.00%	30.50%	30.00%	31.60%
International [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net		$ 2,237,418	$ 2,177,367	$ 4,544,236	$ 4,442,146
Concentration Risk, Percentage		9.60%	10.40%	9.80%	10.60%
Total Consolidated Income from Operations		$ 24,211	$ 15,737	$ (53,695)	$ (13,261)
Consolidated Income from Operations, Percentage		2.30%	1.40%	(3.10%)	(1.10%)
Total Consolidated Net Loss Attributable to Common Shareholders:		$ 48,135	$ 47,470	$ (867)	$ 42,262
Total Consolidated Net Loss Attributable to Common Shareholders: Percentage		22.30%	2822.90%	0.10%	4.50%
Total Consolidated Assets		$ 2,501,001		$ 2,501,001		$ 2,886,735
Consolidated Assets Percentage		3.80%		3.80%		4.80%
U.S - Control States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net		$ 4,519,667	$ 4,365,492	$ 9,831,306	$ 8,644,802
Concentration Risk, Percentage		21.40%	23.30%	23.50%	23.20%
U.S - Open States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net		$ 16,553,078	$ 14,351,291	$ 32,039,009	$ 28,659,489
Concentration Risk, Percentage		78.60%	76.70%	76.50%	76.80%
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Consolidated Sales, net		$ 21,072,745	$ 18,716,783	$ 41,870,315	$ 37,304,291
Concentration Risk, Percentage		90.40%	89.60%	91.20%	89.40%
Total Consolidated Income from Operations		$ 1,024,228	$ 1,143,139	$ 1,786,738	$ 1,226,608
Consolidated Income from Operations, Percentage		97.70%	98.60%	103.10%	101.10%
Total Consolidated Net Loss Attributable to Common Shareholders:		$ (264,271)	$ (49,151)	$ (905,976)	$ (990,340)
Total Consolidated Net Loss Attributable to Common Shareholders: Percentage		(122.30%)	(2822.90%)	99.90%	(104.50%)
Income tax expense, net		$ 217	$ 25,335	$ (17,898)	$ (43,748)
Income tax expense, net Percentage		100.00%	100.00%	100.00%	100.00%
Total Consolidated Assets		$ 62,905,365		$ 62,905,365		$ 57,446,625
Consolidated Assets Percentage		96.20%		96.20%		95.20%
[1]	Sales, net and Cost of sales include excise taxes of $1,752,916 and $1,759,630 for the three months ended September 30, 2018 and 2017, respectively, and $3,587,170 and $3,399,385 for the six months ended September 30, 2018 and 2017, respectively